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1 SUMMARY 
Dendritic cells are the sentinels between the innate and the adaptive immunity. 
They are professionals that capture invading pathogens, recognize specific 
microbial structures and induce naïve T lymphocytes to polarize into a specific T 
cell subset. To initiate the T cell polarization DCs secrete cytokines which are 
induced upon Toll-like receptor activation by microbial structures. The recognition 
of these structures and the discrimination between non-self and self structures by 
TLRs is fine tuned, but under defined circumstances deregulation of immune 
responses appears. Consequently, this can result in immune disorders such as 
autoimmunity, chronic inflammatory diseases or cancer. In this thesis the 
investigations are focused on the regulation of the IL-12 family members IL-12p70 
and IL-23 in DCs. The objective was to investigate three different endogenous and 
exogenous factors that regulate IL-12p70 or IL-23. 
In the first part Selenium, an essential trace element and important factor in 
several metabolic pathways including the cellular redox status and reactive oxygen 
species (ROS) dependent signaling was applied as supplement in immature 
Langerhans cell culture. Because Selenium also plays a role in the immune 
system the TLR-induced IL-23 production of the DCs upon Selenium treatment 
was analyzed. In the immature Langerhans cell line XS-52 the strongest inducer of 
IL-23 was TLR4 ligand LPS. Furthermore increased levels of TLR4-induced IL-23 
in cells treated with Selenium were detected in a concentration dependent 
manner. Whereas the IL-23 subunit p40 was upregulated upon Selenium 
treatment the second subunit p19 was completely unaffected. This effect was 
detected on mRNA and protein level. In addition, as expected, IFN-γ inhibited the 
TLR4-induced IL-23 secretion of both, Selenium treated and untreated cells.  
In the second part of this thesis p47
phox, an organizing protein of the NADPH 
oxidase was analyzed regarding its potential to regulate IL-12p70 and/or IL-23 
secreted by different DC subtypes. Since it was demonstrated that p47
phox 
deficiency is associated with enhanced autoimmunity and chronic inflammation we 
wanted to prove whether it has a function in addition to that within the NADPH 
oxidase. We found some hints that p47
phox may be interact with proteins of the 
TLR signaling pathway and thus we hypothesized that p47
phox may have a function 
for the regulation of TLR-mediated cytokine production in DCs. In several 1 Summary    Richter 
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experiments with DCs from the spleen of different p47
phox deficient mice we 
detected an increased production of TLR9-induced IL-12p70 compared to wild 
type cells. In contrast TLR4 stimulation with LPS displayed no significant 
differences between p47
phox deficient and wild type cells. In spleen cells IL-23 was 
not detected. Confirming the results of this new negative feedback by p47
phox on 
IL-12p70 rats, with a single nucleotide polymorphism in the p47
phox gene, were 
investigated. Interestingly this polymorphism is located in the phosphorylation site 
of IRAK4, an important kinase in the TLR pathway. In rats with a methionine 
residue at this position in the p47
phox protein enhanced IL-12p70 level were found, 
compared to the rats with threonine, which can be phosphorylated by IRAK4. All 
analyzed mice and rats have defects in the NADPH oxidase function due to a non 
functional p47
phox protein which results in a defective ROS production. To 
determine whether the observed negative feedback mechanism is connected to 
the lack of ROS production experiments with gp91
phox deficient mice, which also 
have a defective NADPH oxidase function, were performed. In several 
experiments the enhanced IL-12p70 production in cells from p47
phox deficient mice 
could be confirmed, but no differences between gp91
phox deficient and wild type 
mice have been observed. In further studies was found that the inhibition of the 
NADPH oxidase function did not alter the negative feedback on TLR9-induced IL-
12p70 secretion by p47
phox. Interestingly upon treatment with the inhibitor a 
feedback mechanism in wild type cells also after TLR4 stimulation was observed. 
Hence, blocking a ROS-dependent TLR4 pathway by the inhibitor uncovered the 
LPS induced ROS-independent pathway of the TLR4 signaling. These findings 
strongly approve a NADPH oxidase/ROS-independent function of p47
phox in DCs. 
Because splenic DCs do not secrete IL-23, in vitro differentiated DCs from the 
bone marrow were investigated regarding the negative feedback mechanism. In 
DCs from p47
phox deficient mice, differentiated with GM-CSF, the upregulation of 
IL-12p70 was confirmed, whereas Flt3-L cultured DCs did not display the negative 
feedback. In contrast to IL-12p70 no difference for the IL-23 production between 
wild type and p47
phox deficient cells has been detected. Thus, we concluded that 
IL-23 production is not regulated by p47
phox. IL-12p70 is the major cytokine in the 
Th1 polarization whereas IL-23 is important for the maintenance and survival of 
Th17 cells. To prove whether the regulation of IL-12p70 influences the T cell 
response immunization experiments closely resembling the classical DTH-like 1 Summary    Richter 
3 
 
protocols were performed. Groups of p47
phox deficient and wild type mice received 
either PBS, OVA alone or mixed with TLR9 ligand CpG2216 in IFA s.c. to activate 
and polarize naïve T cells towards Th1 or Th17 cells. After ten days isolated lymph 
node cells were incubated in an ELISA spot assay with or without OVA and the 
frequency of IFN-γ and IL-17 producing T cells was quantified. In vitro recall of 
OVA immunization of wild type and p47
phox deficient mice resulted in an increased 
IFN-γ and IL-17 frequency in the p47
phox deficient cells. The combination with 
CpG2216 as adjuvant and inducer of the 3
rd signal enhanced the frequency of 
IFN-γ and IL-17 producing T cells in wild type mice significantly. However, in 
p47
phox deficient cells the IFN-γ and IL-17 response, being already detectable 
without  in vitro OVA re-stimulation, was strongly augmented upon OVA re-
stimulation. These findings confirmed our in vitro data for IL-12p70. Hence, the 
data supports our hypothesis that the p47
phox dependent regulation of IL-12p70 
and the consequences for the T cell response is an important mechanism to 
prevent uncontrolled immune responses. 
In the last part of this thesis the immunomodulatory property of vitamin D3 on the 
IL-12p70 production of DCs was examined. Since it was shown that VD3 
influences the differentiation and maturation of monocytes and DCs, splenic DCs 
from C57BL/6 and BALB/c mice were investigated regarding their IL-12p70 
production after VD3 treatment. Spleen cells, stimulated with LPS or CpG2216, 
exhibited a decreased IL-12p70 production when treated with VD3 before 
stimulation phase. In contrast treatment with VD3 only during TLR stimulation had 
no influence on the IL-12p70 production. Since it was demonstrated that VD3 
stimulates the expression of p47
phox mRNA cells from p47
phox deficient mice were 
also treated with VD3. In initial experiments only a slight inhibition of IL-12p70 has 
been detected in p47
phox deficient cells compared to the wild type. 
In summary the thesis displays three different possibilities to influence the TLR-
induced cytokine secretion of DCs, although with different intensities and 
specificities.  
 2 Introduction    Richter 
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2 INTRODUCTION 
2.1 Innate and adaptive immunity 
2.1.1 Innate immunity – antigen presenting cells 
The innate immunity is a universal and ancient system of host defense against 
invading pathogens. Components of the innate immunity are physical and 
chemical barriers, blood proteins including the complement system and phagocytic 
cells such as neutrophils, macrophages and dendritic cells (DCs). Microorganisms 
penetrating the epithelial surface are sensed immediately by phagocytic cells that 
engulf the microbes upon binding to their cell surface (Janeway, 6
th edition). In 
parallel proteins of the complement system get activated and initiate proteolytic 
reactions against the invading pathogens. Specific pattern recognition receptors 
(PRRs), which are germline encoded and located on the cell surface or in 
intracellular compartments of phagocytic cells such as DCs recognize common 
structures of microorganisms and lead to the induction and secretion of cytokines 
such as interleukins, interferons and chemokines (Janeway, 1989; Medzhitov, 
2002; Janeway, 2002; Akira, 2006). Release of those proteins by phagocytic cells 
initiates the process of inflammation which is characterized by heat, pain, redness 
and swelling triggered by vasodilation and an increasing permeability of the blood 
vessels (Janeway, 6
th edition). In the initial phase primarily neutrophils are 
recruited to the site of inflammation where they engulf and destroy the pathogens. 
Shortly after monocytes arrive and differentiate into macrophages which 
supporting the reaction. During these activities DCs loaded with pathogens 
migrate from the peripheral tissue via afferent lymphatics to the regional lymph 
nodes. The mature DCs present pathogenic antigens to naïve T lymphocytes via 
their major histocompatibility complex (MHC). Because DCs discriminate between 
self and non-self antigens an activation of T lymphocyte response depends on co-
stimulatory molecules such as B7.1 (CD80) or B7.2 (CD86) expressed by DCs 
upon PRR stimulation. Those molecules interact with the T lymphocyte receptor 
CD28. In parallel DCs secrete different cytokines upon PRR stimulation that are 
necessary for the differentiation of naïve T lymphocytes into specific T helper (Th) 
cells. Thus, DCs producing the cytokine interleukin (IL) -12 initiate the 2 Introduction    Richter 
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development of Th1 cells whereas IL-23 results in the proliferation of Th17 cells 
(Mosmann, 1989; Aggarwal, 2003, Langrish, 2005). 
2.1.2 Adaptive immunity – T lymphocytes 
In contrast to the innate immune recognition which is characterized by a spectrum 
of germline-encoded receptors the adaptive immunity consists of B and T 
Lymphocytes that respond to specific antigens presented by antigen presenting 
cells (APCs) such as DCs. The main differences between the innate and the 
adaptive immunity are listed in the table below (Table 1). 
 
Table 1: Innate and adaptive immunity (Janeway et al., 2002) 
 
Naïve T lymphocytes circulate continuously between the blood and the lymphoid 
organs via high endothelial venules. Upon contact with antigen loaded APCs in 
lymphoid organs naïve T lymphocytes differentiate and proliferate to effector cells. 
After several days proliferated effector T lymphocytes migrate to the site of 
infection. Thus, effector T lymphocytes reenter the blood stream and are recruited 
to the infected tissue by expression of selectins (P- and E-selectin), adhesion 
molecules and chemokines on the vascular endothelium (Dustin, 1991, Springer, 
1995). T lymphocytes can be divided into two main subtypes: T helper (Th) 
lymphocytes characterized by the expression of CD4 and cytotoxic T lymphocytes 
(CTL) that express CD8 on their surface. Whereas Th lymphocytes were activated 
via MHC class II molecules CTLs recognize MHC class I on the surface of DCs. In 
contrast to MHC class II molecules expressed by antigen presenting cells MHC 2 Introduction    Richter 
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class I molecules are expressed on the surface of many cells in order that 
intracellular viruses and other pathogens can be recognized by immune cells. 
CTLs are effector cells that directly respond to infected cells by releasing of 
cytotoxic proteins such as Perforin, Granzymes and Granulysin from lytic granules 
(Barry, 2002). Consequently it is clear that CTLs require a stronger co-stimulation 
either directly by antigen presenting cells via B7 molecules that bind CD28 on 
CTLs or by the presence of Th cells. Unlike CTLs different subtypes of Th cells are 
described, some are discovered quiet recently. The classical subtypes Th1 and 
Th2 are described in the late eighties by Mosmann et al. (Mosmann, 1989). Th1 
cells are defined by their clearance of intracellular pathogens and the production of 
interferon (IFN) -γ. In contrast Th2 cells control specific parasitic infections through 
the production of interleukin 4 (IL-4), IL-5 and IL-13. Deregulation or uncontrolled 
activation of Th1 and Th2 cells, respectively are associated with immune 
pathogenesis. Whereas Th1 cells have been linked to autoimmune reactions Th2 
cells are associated with atopy and asthma. Recently a distinct subtype called 
Th17 was described (Wynn, 2005; Langrish, 2005 JEM). Characteristic for those 
cells is the production of IL-17 and their impact on autoimmune diseases and 
recently described also tumorigenesis (Cua, 2003; Murphy, 2003; Langrish 2003; 
Langowski, 2006; Kortylewski, 2009). 
 
2.2 Autoimmunity 
In normal healthy state self-tolerance mechanisms exist. These mechanisms 
include the discrimination between self and non-self antigens. Already in the early 
stage of lymphocyte development selection of nonself-reactive from self-reactive 
lymphocytes is performed. Impaired function of this system often results in 
autoimmune diseases which can be divided in systemic or organ-specific 
autoimmune diseases. Prominent examples for systemic autoimmune reaction are 
systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA). They are 
defined by characteristic auto-antibodies such as antibody against chromatin in 
SLE or the rheumatoid factor (RF) against the fragment crystallizable (Fc) region 
of the immunoglobulin G (IgG) in RA. Because systemic autoimmune diseases 
affect multiple organs and auto-antibodies can not be cleared from the body they 
often become chronic. In addition to the systemic autoimmune diseases organ-2 Introduction    Richter 
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specific autoimmune diseases are limited to one or a few organs such as 
inflammatory bowel diseases (IBD) or type I insulin-dependent diabetes mellitus 
(T1D) or multiple sclerosis (MS). In T1D the immune system attacks the insulin 
producing pancreatic β cells which leads to the complete loss of insulin production 
(Green, 1999). MS is an autoimmune disease characterized by the destruction of 
myelin sheath of the central nervous system that at least influences the signal 
conductivity of the neurons (Steinman, 1996). Autoimmune diseases were often 
connected to genetic and environmental risk factors, respectively. Several studies 
have shown that sun light exposure and thus the Vitamin D3 (VD3; 1,25-
dihydroxycholecalciferol; 1,25-(OH)2D3) level is one environmental factor 
connected to MS or T1D (Cantorna, 2000; The EURODIAB substudy 2 study 
group, 1999). In addition genetic risk factors as trigger for autoimmune diseases 
are increasingly described. Genetic loci associated with autoimmune disorders 
often encode for genes important during immune response such as intracellular 
signaling molecules and PRRs, transcription factors, cytokines and cytokine 
receptors, membrane receptors and co-stimulatory molecules (Table 2). Interferon 
regulatory factor (IRF) 5 has been associated with SLE and the IBD ulcerative 
colitis (Sigurdsson, 2005; Sigurdsson, 2008; Graham, 2005; Graham, 2007; 
Harley, 2008; Hom, 2008). Furthermore signal transducer and activator of 
transcription (STAT) 4, a key molecule in the IL-12p70 signaling pathway, was 
identified as a risk gene for autoimmune diseases (Remmers, 2007). In patients 
treated with anti-rheumatic drugs the high expression of STAT4 in DCs in the 
synovium disappears (Walker, 2006). In addition to the transcription factors also 
cytokines and its receptors are associated with autoimmune diseases such as the 
IL-23 receptor (Duerr, 2006; Barret, 2008). Because there is also an association of 
IL-12p40 with the IBD Crohn’s disease and psoriasis the balance between both 
cytokines IL-12p70 and IL-23 seems to be important for the pathogenesis of these 
diseases (Cargill, 2007; Nair, 2007; Barret, 2008). 
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Table 2: Genetic loci associated with autoimmune diseases (Gregersen et al., 2009) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aAbbreviations: AITD, autoimmune thyroid disease; AS, ankylosing spondylitis; CD, 
Crohn’s disease; GD, Graves’ disease; MS, multiple sclerosis; PSA, psoriatic arthritis; 
PSO; psoriasis; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; T1D, type 1 
diabetes 2 Introduction    Richter 
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2.3 Dendritic cells 
DCs are sentinels and widely distributed through the body. They are specialized to 
capture, process and present antigens to naïve T cells and induce different T cell 
responses or tolerance (Banchereau and Steinman, 1998). Several subtypes of 
DCs differ in their location, migratory pathways and immunological function 
(Shortman and Liu, 2002). In an immature state DCs screen the peripheral tissue 
for foreign antigens and capture them. Loaded with the pathogenic structure they 
migrate to the lymph node where they achieve a mature phenotype. DCs have a 
hematopoietic origin and invade as precursor cells (pre-DCs) lymphoid and non-
lymphoid tissues were they rest. Pre-DCs are plasmacytoid DCs (pDCs), 
precursor of conventional DCs (cDCs) and monocytes (Shortman and Naik, 2007, 
Onai 2007). They share a common progenitor in the bone marrow (BM) known as 
macrophage and DC precursor (MDP) that is characterized by the expression of 
Fms-like tyrosine kinase 3 (Flt3) (Liu, 2009). Consequently it is clear why 
differentiation from pre-DCs into cDCs and pDCs requires Flt3-(ligand)L. Although 
granulocyte macrophage-colony stimulating factor (GM-CSF) is also effective for 
the generation of DCs from BM progenitors it is not essential. In mice lacking GM-
CSF numbers of steady state DCs in lymphoid tissues was not or only slightly 
altered (Vremec, 1997). In contrast monocytes from the BM differentiate into 
inflammatory DCs upon cultivation with GM-CSF (Sallusto, 1994). Typical 
monocytes-derived cells are immature Langerhans cells in the skin (Ginhoux, 
2006). 
 
2.3.1 Conventional dendritic cells 
Conventional DCs in steady state appear in lymphoid and non-lymphoid tissues 
and in the circulation (Wu, 2007). Lymphoid tissues containing resident cDCs are 
thymus, spleen and lymph nodes. Subtypes of cDC are localized in different 
tissues such as in the skin (Langerhans cells and dermal DCs), the liver, the 
mucosa and the lung. In addition to the resident cDCs which are immature and 
active for antigen uptake and processing migratory cDCs exist (Wilson, 2003). 
They have a mature phenotype and shutdown their antigen uptake function. 
Furthermore cDCs differ in the expression of their surface cluster of differentiation 2 Introduction    Richter 
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(CD) marker and their cytokine production upon activation by microbial stimuli. 
Immature cDCs in spleen and lymph nodes can be divided in a CD8
+ or CD8
- 
phenotype. The subtype of CD8
+ cDCs that is also CD4
-, CD205
+ and CD11b
- was 
described as the main producer of IL-12p70 (Reis e Sousa, 1997, 1999; Hochrein, 
2001). In contrast CD8
- and CD4
- cDCs produce high amounts of IFN-γ in 
response to IL-18 but no IL-12p70 or IFN-α (Hochrein, 2001). cDCs differentiated 
from pre-DCs of the BM are highly CD11c
+, CD11b
+, CD45RA
- and B220
- and 
thereby differ clearly from pDCs described below (Diao, 2004).          
 
2.3.2 Plasmacytoid dendritic cells 
Although cDCs and pDCs share a common precursor, the morphology and the 
phenotype of pDCs differ from cDCs. They are round without dendrites, circulate, 
relatively long-lived and known as the natural type I IFN-producing cell (Liu, 2005). 
They express specific PRRs recognizing microbial and viral RNA and DNA. Upon 
activation by these stimuli pDCs mature towards a cDC-like phenotype and 
produce large amounts of type I IFN (Asselin-Paturel, 2001). Although in the 
mature state they exhibit a cDC-like population they are poor antigen presenting 
cells and consequently have a weak capacity to stimulate T cells (Asselin-Paturel, 
2001; Krug, 2003). Depending on the maturation state of pDCs they are 
characterized by their expression of B220, CD45RA, CD11c, Ly6C and GR-1 
(Asselin-Paturel, 2001; O’Keeffe, 2002). In contrast to cDCs they do not express 
CD11b and CD205 such as cDCs and furthermore do not respond to bacterial 
products (Asselin-Paturel, 2001; O’Keeffe, 2002). pDCs are also described as 
regulators of the immune response because they activate naïve T lymphocytes to 
produce IL-10 (Liu, 2005). Recent publications describe the T lymphocyte homing 
chemokine receptor CCR9 as a marker for the tolerogenic phenotype of pDCs 
(Hadeiba, 2008; Wendland, 2007). CCR9 is exclusively expressed on immature 
pDCs which are efficient to induce regulatory T lymphocytes (Hadeiba, 2008).  
 
2.4 Toll-like receptors 
Toll-like receptors (TLRs) are PRRs that recognize pathogen-associated molecular 
patterns (PAMPs). The entire family of TLRs discovered consists of 13 subtypes, 2 Introduction    Richter 
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which recognizes a variety of PAMPs (Table 3; Akira, 2006). TLRs are type I 
transmembrane proteins composed of three domains. First the ectodomain which 
consists of leucine-rich repeats (LRRs) mediate the recognition of the respective 
PAMPs. Second the transmembrane domain and third an intracellular domain that 
is known as the Toll/IL-1 receptor (TIR) domain. This domain is homologous to 
that of the IL-1R and is required for the initiation of downstream signaling 
pathways (Bowie and O’Neill, 2000). TLRs differ in their localization in the cell. 
Some TLRs are expressed on the cell surface and others are localized intracellular 
in different compartments such as endosome, lysosome or the endoplasmatic 
reticulum (ER). TLRs located on the cell surface include TLR1, TLR2, TLR4, 
TLR5, TLR6 and TLR11. Typical intracellular TLRs are TLR3, TLR7, TLR8 and 
TLR9. Apart from a cell membrane and intracellular location of TLRs additionally 
their downstream signaling components differ regarding adaptor molecules and 
subsequent kinase cascades. Two main adaptor molecules mediate the signaling 
upon TLR activation are described (Akira, 2004). Myeloid differentiation primary 
response gene 88 (MyD88) is the universal adaptor for all TLRs except TLR3. 
Signals via MyD88 activate inflammatory pathways. The association of TLRs and 
MyD88 results in the recruitment of IL-1R-associated kinase (IRAK) family 
members such as IRAK1, IRAK2, IRAK4 and IRAK-M. Phosphorylation of IRAKs 
leads to the dissociation from MyD88 and that result in the interaction with the 
tumor necrosis factor (TNF) receptor-associated factor (TRAF) 6. This interaction 
promotes the activation of the transforming growth factor (TGF) -activated kinase 1 
(TAK1) that is combined with TAK1-binding protein (TAB) 1, TAB2 and TAB3. 
Subsequently TAK1 activates the inhibitor of nuclear factor-κB (IκB)-kinase (IKK) 
complex composed of the catalytic subunits IKKα and IKKβ and the regulatory 
subunits IKKγ/nuclear factor-κB (NF-κB) essential modulator (NEMO) which then 
supports the phosphorylation of the IκB proteins. Degradation of the IκB proteins 
results in the NF-κB translocation to the nucleus. Simultaneously TAK1 activates 
the mitogen-activated protein kinase (MAPK) pathway which mediates the 
activation of the transcription factor AP-1. In addition IRF5 is recruited to the 
MyD88-IRAK4-TRAF6 complex, phosphorylated and translocated to the nucleus. 
NF-κB, adaptorprotein-1 (AP-1) and IRF5 induce the transcription of inflammatory 
cytokine genes. TIR-containing adaptor inducing IFN-β (TRIF) is the second 
important adaptor molecule of the TLR signaling pathway. Whereas TLR4 2 Introduction    Richter 
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activation resulted in the recruitment of both, MyD88 and TRIF TLR3 exclusively 
mediates its signal via the adaptor TRIF. The signaling cascade downstream the 
adaptor TRIF is also via TRAF6 and TAK1 but additionally TRAF3 is recruited 
which subsequently activates the TRAF family member-associated NF-κB 
activator (TANK) binding kinase 1 (TBK1)/IKKi complex that phosphorylates IRF3. 
In contrast to NF-κB and AP-1, which induce inflammatory cytokines, IRF3 
regulates the expression of type I interferons in the TRIF-dependent pathway.  
 
Table 3: Recognition of PAMPs by the different TLRs (Akira et al., 2006) 
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2.4.1 Toll-like receptor 4 
TLR4 recognizes lipopolysaccharides (LPS), a major membrane compound of 
Gram-negative bacteria. For a robust induction of cytokines TLR4 requires a tight 
association with another LRR protein, MD-2 which functions as a LPS-binding 
component on the cell surface. Furthermore LPS-binding protein (LBP) and CD14 
localized in the cell membrane or cytoplasm are involved in the response to LPS 
(Miyake, 2007). TLR4 activates both signaling pathways the MyD88-dependent 
and alternatively the TRIF-dependent pathway. Whereas other TLRs such as 
TLR2 and TLR5 induce only proinflammatory cytokines TLR4 can induce both, a 
proinflammatory and an IFN response (Kawai and Akira, 2006). These differences 
can be explained by further adaptor proteins that determine which pathway 
downstream of TLR4 is activated. For example the combination of TIR domain-
containing adaptor protein (TIRAP) and MyD88 activates the MAPK and NF-κB 
pathway resulting in a pro-inflammatory response, whereas in contrast TRAM and 
TRIF activate TBK1 and IκB that then induce a type I IFN response (Barton, 
2009). Although it is generally believed that the two pathways are induced 
simultaneously, in a recent publication Kagan et al. demonstrated that they are 
activated sequentially. In the first step LPS-activated TLR4 in combination with the 
adaptor complex MyD88-TIRAP is endocytosed. During the early endosome 
formation the MyD88-TIRAP complex is released from the membrane and the 
TRAM-TRIF complex engage the TIR domain of the TLR4 and induce the second 
step leading to the gene expression of type I IFN (Kagan, 2008). In addition to LPS 
TLR4 recognizes envelope proteins of viruses such as respiratory syncytial virus 
or mouse mammary tumor virus (Akira, 2006). Furthermore TLR4 and another cell 
surface receptor, TLR2 are also implicated in the recognition of endogenous 
molecules such as heat shock proteins, fibrinogen, hyaluronic acid, fatty acids, 
high-mobility group box 1 (HMGB1) and β-defensin 2 which are released during 
inflammation. Thus, these TLRs not only recognize exogenous structures of 
microbes but may be sensors for endogenous danger signals (Miyake, 2007).  
 
2.4.2 Toll-like receptor 9 
In contrast to TLR4 which is localized on the cell membrane, TLR9 is an 
intracellular receptor and localized in the endosome, lysosome or ER. TLR9 is 2 Introduction    Richter 
11 
 
primarily expressed on pDCs and B cells (Hemmi, 2000; Takeshita, 2001; 
Hornung, 2002) and recognizes unmethylated CpG motifs in DNA. In pDCs TLR9 
act as a sensor of viral infections (Lund, 2003; Krug, 2004; Krug, 2004). Prior 
stimulation TLR9 is resident in the ER but upon stimulation TLR9 rapidly 
translocates to the endolysosomes (Latz, 2004). During this process the TLR9 is 
cleaved by proteases, passes through the Golgi and sorted to the endolysosomal 
system (Ewald, 2008). Although in different DCs TLR9 stimulation induces the 
expression of proinflammatory cytokines only in pDCs TLR9 stimulation results in 
a strong IFN-α production. These differences in response to TLR9 ligands can 
possibly be explained by the expression of IRF7 exclusively in pDCs (Honda, 
2005). In this context IRF7 forms a complex with MyD88, IRAK1, IRAK4 and 
TRAF6 and translocates to the nucleus (Kawai, 2004; Honda, 2004). Synthetic 
CpG-containing oligodeoxynucleotides (ODNs) are potent ligands for TLR9. Type 
A ODNs such as CpG2216 (human TLR9 agonist) are characterized by mixed 
phosphodiester-phosphorothioate backbones and a single hexameric purine-
pyrimidine-CG-purine-pyrimidine motif flanked by self-complementary bases that 
form a stem loop with a poly-G tail at the 3’ end (Verthelyi, 2001). In contrast type 
B ODNs such as CpG1668 (mouse TLR9 agonist) have phosphorothioate 
backbones that contain thymine cytosine guanine (TCG) motifs. Although both 
types (A and B) can induce IFN-α in pDCs, type A ODNs fail to stimulate B cells 
(Verthelyi, 2001; Krug, 2001). When both ODNs are applied simultaneously, type 
B ODN suppress the type A ODN induced secretion of IFN-α (Gursel, 2002).   
 
2.5 Cytokines 
Cytokines are immunomodulating products of immune cells such as interleukins, 
chemokines, interferons and tumor necrosis factors that mediate many functions of 
these cells. In parallel to inflammatory and regulatory cytokines produced during 
an immune response growth and differentiation factors exist that are primarily 
necessary for the development of cells. In response to microbial stimuli 
phagocytes and DCs secrete cytokines such as IL-12p70, IL-23 or IFN-α. The 
release of these cytokines activates in turn cells of the innate and adaptive 
immunity such as natural killer (NK) cells and T cells, respectively to produce 2 Introduction    Richter 
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TNFα, IFN-γ or IL-17. In the following sections cytokines investigated in the 
context of this thesis are described in detail. 
 
2.5.1 Interleukin-12 
Kobayashi et al. identified a 70 kD glycoprotein produced by an Epstein-Barr-
Virus-transformed B cell line that activates and enhances the cytotoxicity and IFN-
γ secretion of NK cells (Kobayashi, 1989). This protein, better known as IL-12p70 
is a heterodimeric cytokine composed of the subunits p35 and p40 and induces 
Th1 cell response (Hsieh, 1993; Manetti, 1993). IL-12p70 further promotes the 
expansion and activity of CTLs both directly and indirectly by Th1 cells (Colombo 
and Trinchieri, 2002). In addition to the virus-transformed B cell lines, where IL-
12p70 was discovered, DCs and monocytes are known as the main IL-12p70 
producers in response to microbial stimuli (Mosmann, 1989; D’Andrea, 1992; 
Macatonia, 1995). Although the gene expression of both subunits is regulated 
independently they have to be expressed in one cell. Whereas the expression of 
the subunit p35 is tightly regulated and therefore the rate limiting step for the 
formation of the bioactive heterodimer, p40 is expressed at quantities higher than 
required (Snijders, 1996). Thus, it is clear that p40 also forms homodimers that 
have been never found for p35 (Wolf, 1991). Both p40 mono- and homodimers 
have been proposed as natural inhibitors for bioactive IL-12p70 (Gillessen, 1995). 
IL-12p70 is initially induced rapidly and independent of T cell signals such as IFN-γ 
(Scharton-Kersten, 1996). The pro-inflammatory cytokine IL-12p70 needs to be 
strictly controlled by negative and positive regulatory mechanisms. Microbial 
products including bacterial wall components, structures of fungi and parasites, 
bacterial and viral RNA and DNA that are recognized by TLRs are strong inducers 
of IL-12p70 (Ma, 2001). Thereby the amount of IL-12p70 depends on the 
expression pattern of TLRs in the different subsets of DCs and phagocytes. During 
the inflammatory response IL-12p70 is enhanced by IFN-γ produced by Th1 or NK 
cells via a positive feedback mechanism (Ma, 1996; Hayes, 1998). Furthermore 
stimulation of CD40 expressed by DCs through CD40 ligand expressed by T cells 
increases the production of IL-12p70 (Bianchi, 1999; Schulz, 2000). Interestingly 
also Th2 derived cytokines IL-4 and IL-13 enhances IL-12p70 by induction of gene 2 Introduction    Richter 
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expression of both subunits p35 and p40 (D’Andrea, 1995; Marshall, 1997). All of 
these positive enhancers of IL-12p70 production serve as regulators for an 
adequate immune response upon microbial invasion. In contrast inhibitory 
mechanisms for IL-12p70 are needed to avoid uncontrolled, dysregulated immune 
responses. Maintaining the fine balance between immune reaction against 
pathogens and detrimental systemic inflammation potent inhibitors of IL-12p70 
such as IL-10 are expressed. IL-10 suppresses the transcription of both subunits 
p35 and p40 (Aste-Amezaga, 1998; Demangel, 2002; Xia, 2003). In addition 
transforming growth factor β influences the p40 mRNA stability (Du, 1998). 
Furthermore type I interferons inhibit the IL-12p70 production in mature DCs 
(Heystek, 2003). Surprisingly the pro-inflammatory cytokine TNFα is also able to 
suppress IL-12p70 (Ma, 2001). Cells influenced by IL-12p70 such as T cells, NK 
cells and also DCs and B cell lines express the IL-12p70 receptor (IL-12R). The IL-
12R is composed of the IL-12Rβ1 and IL-12Rβ2 chain that activates the janus 
kinase (JAK)/STAT pathway mainly via STAT4 (Thierfelder, 1996; Kaplan, 1996). 
During immune response activation of T cells through the TCR induces the 
expression of the IL-12R chains. Furthermore transcription is enhanced by IL-
12p70 itself, IFN-α, TNF and through co-stimulation of CD28. Several years ago it 
was discussed whether under defined circumstances the deregulation of IL-
12p70/Th1 pathway are the main cause for the development of autoimmune 
reactions. Since the discovery of other IL-12 family members such as IL-23 and IL-
27 it was shown that IL-12p70 and the resulting Th1 response are not the main 
players in autoimmune diseases (Becher, 2002; Gran, 2002; Cua, 2003; Murphy, 
2003; Hunter, 2005). All known IL-12 family members and their receptors are 
represented in the figure below (Fig.1). 
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Fig. 1: IL-12 family and their respective receptors.  
IL-12p70 is composed of the subunits p35 and p40. IL-23 shares with IL-12p70 the 
subunit p40 and additional consist of the subunit p19. The third member is IL-27 that is 
composed of the subunits p28 and EBI3. (Goriely et al., Nature, 2008) 
 
 
Whereas the role of IL-12p70 in autoimmune diseases is controversial, its anti-
tumor potential has been described in several publications (Gerosa, 2002; Kaplan, 
1998; Shankaran, 2001; Colombo, 2002; Trinchieri, 2003; Airoldi, 2009). Herewith 
a clear opposite function between the two IL-12 family members, IL-12p70 and IL-
23, became evident (IL-23 is described in the next section).  
  
2.5.2 Interleukin-23 
With the discovery of IL-23 in the year 2000 a new member of the IL-12 family was 
found (Oppmann, 2000). IL-23 consists of p40, the common subunit with IL-12p70, 
and the unique subunit p19. IL-23 is produced by DCs upon TLR activation 
through microbial stimuli. In comparison to IL-12p70 that induces a Th1 response 
IL-23 promotes the expansion and survival of Th17 cells, a new T cell subset 
characterized by the production of IL-17 (Langrish, 2005). The receptor for IL-23 is 
expressed on T cells and NK cells and is composed of the recently cloned IL-23R 
and IL-12Rβ1, of which the latter in turn is also a moiety of the IL-12R (Parham, 2 Introduction    Richter 
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2002). Although IL-23 and IL-12p70 are both secreted by DCs and have 
comparable functions for the immune response, IL-23 is causative for several 
autoimmune diseases as shown by different groups recently. In a transgenic 
mouse model overexpression of p19 led to multi-organ inflammation, runting, 
infertility and premature death (Wiekowski, 2001). IL-23 is also responsible for the 
establishment and maintenance of different autoimmune diseases as shown in 
animal models for collagen-induced arthritis (CIA), experimental autoimmune 
encephalomyelitis (EAE) or IBD, whereas p19-deficient mice are resistant to these 
diseases (Cua, 2003; Murphy, 2003; Ghilardi, 2004; Langrish, 2005; Yen, JCI, 
2006).  
Furthermore an in vivo study using a monoclonal antibody against p19 
demonstrates reduced EAE in mice (Chen, 2006). Although IL-23 drives 
autoimmune diseases like IL-12p70, at the same time it has an opposite role to IL-
12p70 in tumorigenesis. IL-23 reduces CD8
+ T cells in tumor and promotes tumor 
angiogenesis (Langowski, 2006, 2007). Recent findings for the transcription factor 
STAT3 that is overexpressed in tumors may clarify the different functions of IL-
12p70 and IL-23 regarding tumorigenesis. Thereby STAT3 signaling in the tumor 
microenvironment shifts an anti-tumor IL-12p70 program to a pro-tumor IL-23 
program through the transcriptional activation of the IL-23 subunit p19 and 
simultaneously augments the transcriptional suppression of the IL-12p70-specific 
p35 gene. This transcriptional regulation in tumors was observed by co-activation 
of the p19 promoter with NF-kB/p65 and on the other hand a suppression of c-Rel 
binding to the p35 promoter (Kortylewski, 2009).  
 
2.5.3 Interferon-α 
Type I IFN in general was discovered as a protein secreted by cells infected with 
an inactivated influenza virus. This protein was able to interfere with the viral 
replication and the viral cell entry which established the name “interferon” (Isaacs 
and Lindenmann, 1987). Since the discovery of IFNs two main subtypes of the IFN 
family are known, type I IFNs which include IFN-α and IFN-β and type II IFNs with 
their most prominent protein IFN-γ (described below). IFN-α is mainly produced by 
pDCs upon viral infections or stimulation with bacterial CpG-containing DNA. In 
addition to its direct antiviral activity IFN-α also has immunomodulatory functions. 2 Introduction    Richter 
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During viral infection IFN-α enhances the production of IL-12p70 by cDCs. 
Interestingly several studies showed that high levels of IFN-α applied exogenously 
decrease the expression of the p40 subunit (Cousens, 1997; Dalod, 2002). 
Inhibition of IFN-α signaling or depletion of pDCs recovers the IL-12p70 production 
(Dalod, 2002). In contrast low amounts, which are comparable to the endogenous 
levels of IFN-α during an infection, increase the efficiency of the p35 transcription 
(Gautier, 2005). Furthermore IFN-α increases the cytotoxic properties of NK cells 
and macrophages (Ortaldo, 1983). As described above in addition to the IL-12p70 
production IFN-α supports the maturation of cDCs and induces the proliferation of 
regulatory T cell (Ito, 2001). IFN-α enhances the expression of MHC-I molecules 
which results in an increased presentation of viral but also self antigens (Biron, 
1999; Biron, 2001). Because IFN-α exhibits such a complex and important role in 
the immune response several studies investigating the potential of recombinant 
IFN-α in clinical applications have been performed both to use its antiviral as well 
as anti-tumor potential (US NIH, clinicaltrials.gov).   
 
2.5.4 Interferon-γ 
IFN-γ was first detected 40 years ago as an antiviral IFN (Wheelock, 1965). T 
lymphocytes and NK cells are the main sources of IFN-γ, but also B cells, 
macrophages, and DC produce IFN-γ (Yoshimoto, 1997; Puddu, 1997; Ohteki, 
1999). Induction of IFN-γ is initiated by the IL-12p70 production of antigen-
presenting cells such as DCs. In turn IFN-γ increases the IL-12p70 production in a 
positive feedback loop (described in 2.5.1). IFN-γ represents the characterizing 
cytokine for a Th1 response. During inflammatory responses IFN-γ suppresses the 
production of regulatory IL-10 (Flores, 2007). The IFN-γ receptor consists of two 
chains, the IFN-γR1 and IFN-γR2. Whereas the IFN-γR1 binds the ligand IFN-γ the 
second chain IFN-γR2 is necessary for the functional receptor complex and the 
signal transduction. The signals upon receptor activation are transferred via the 
Jak/STAT1 pathway, whereas the different JAKs are interchangeable (Kotenko, 
1996). Release of IFN-γ, stimulated by activated DCs correlates with a potent 
tumor-specific cytolytic activity (Furomoto, 2004; Miconnet, 2002; Vicari, 2002).  
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2.5.5 Interleukin-17 
IL-17 is a proinflammatory cytokine produced by activated T lymphocytes (Th17) 
and was originally described as CTL-associated antigen 8 and later identified as 
IL-17 (Rouvier, 1993; Yao, 1995). IL-17 stimulates epithelial, endothelial and 
fibroblastic cells to express different proinflammatory cytokines such as IL-6 and 
IL-8 (Kolls, 2004). Five family members of IL-17 have been discovered (IL-17A-F) 
whereas only IL-17A, IL-17E and IL-17F are characterized in considerable detail 
(Moseley, 2003). IL-17A and IL-17F equally produced by Th17 cells can form 
heterodimers. In the differentiation of Th17 cells two major transcription factors are 
involved, STAT3 and retinoid-related orphan receptor (ROR)-γt. Furthermore, for a 
differentiation of IL-17 producing T cells from naïve lymphocytes IL-6 and TGFβ 
are required (Bettelli, 2006; Veldhoen, 2006; Mangan, 2006). Although for their 
initial differentiation IL-23 only plays a minor role, the expansion and survival of 
Th17 cells depends on IL-23, produced by DCs (Veldhoen, 2006). Although Th17 
cells lack the ability of self-amplification such as Th1 and Th2 cells, they produce 
the cytokine IL-21 which induces the expression of the IL-23 receptor on Th17 
cells and thus supports the expansion of these cells (Zhou, 2007). IL-23 also 
induces its own receptor on T lymphocytes (Langrish, 2005; Chen, 2007). Several 
groups showed that IL-17 production is strongly connected to autoimmune 
diseases and chronic inflammation. IL-17 is increased in the synovium of RA 
patients and may be involved in the development of MS, as exemplified in EAE 
models (Kotake, 1999; Lock, 2002). Furthermore IL-17 is elevated in patients with 
an active IBD and psoriasis (Fujino, 2003; Zaba, 2007).    
 
2.6 Selenium 
Selenium, an essential trace element, is an important factor in several metabolic 
pathways including the cellular redox status and ROS dependent signaling, the 
thyroid hormone metabolism and also immune functions (Beckett and Arthur, 
2005; Cunningham-Rundles, 2005; Ryan-Harshman and Aldoori, 2005).  In the 
inorganic form Selenium is incorporated as selenocysteine at the active site of 
many selenoproteins. These selenoproteins are mostly members of the 
glutathione peroxidase (GPx) and thioredoxin reductase (TR) families (Allan, 1999; 
Schrauzer, 2000; McKenzie, 2002). Because selenoproteins are involved in many 2 Introduction    Richter 
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inflammatory cytokine signaling pathways, e.g. IL-1, Selenium has important 
functions in the immune system. In 2003 Matsue et al. reported that ebselen (2-
phenyl-1,2-benzisoselenazol-3(2H)-one or PZ51), an organic Selenium-containing 
compound with different antioxidant activities, efficiently inhibits the LPS-induced 
cytokine production of immature Langerhans cell line (iLCs, XS-52), the DC 
dependent proliferation of Th1 and Th2 cells and the ROS production of BM DCs 
and iLCs (Matsue, 2003). In contrast HIV-positive individuals have diminished 
Selenium levels that were associated with decreased Th1 cytokine production 
(Baum, 2000). In mice the supplementation with Selenium results in decreased 
skin damage and tumor formation upon UVB light exposure (Overvad 1985; 
Pence, 1994). In humans subnormal levels of Selenium have been associated with 
an increased risk to develop skin cancer (Clark, 1984). In a study in 2005 it was 
demonstrated that Selenium levels can be associated with tumorigenesis in a 
chemical induced tumor model in rats (Björkhem-Bergman, 2005). On the contrary 
there are investigations in humans regarding the prevention of tumorigenesis by 
Selenium (Clark, 1996; Lippman, 2009). Analyzing these contrasting studies it 
appears likely that divergent roles of Selenium could possibly be explained by the 
different concentrations applied. Hence, it was shown that very low (<10 nM) and 
very high doses (>10 µM) resulted in cell death. While on the one hand moderate 
levels of Selenium exhibit antioxidant properties increasing concentrations may 
reverse its protective potential into a strong oxidative reagent (reviewed in 
Selenius, 2009).  
 
2.7 Different roles of p47
phox 
2.7.1 p47
phox as component of the NADPH oxidase 
The nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is a multi 
subunit complex enzyme converting molecular oxygen into superoxide anion (O2
-) 
(Babior, 2004; Cross, 2004). This enzyme is mainly expressed by neutrophils, 
eosinophils, monocytes and macrophages. During microbial infections the 
activation of the NADPH oxidase is an important innate function to kill invading 
pathogens (Segal, 2005; Nathan, 2006). In further enzymatic processes O2
- is 
used for production of reactive oxygen species (ROS) supporting phagocytic 
reactions to defend pathogenic components. The NADPH oxidase complex 2 Introduction    Richter 
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consists of membrane (Cybb/gp91/NOX2, Cyba and small G-protein Rap1A) and 
cytosolic (p40
phox, p47
phox, p67
phox and small G-proteins Rac2 and Cdc42) 
components (Fig. 2; Sheppard, 2005). The cytosolic subunit p47
phox is necessary 
for the activation of the NADPH complex, to which end it is phosphorylated by 
serine and threonine kinases (Ago, 2003; Dang, 2006; Johnson, 1998). 
Phosphorylation of p47
phox unmasks a PX-domain and allows the transport of 
p67
phox and the interaction with the membrane located cytochrome b558/Cybb 
(Sheppard, 2005). Only this complete NADPH complex is active and functional to 
produce ROS. 
 
Fig. 2: Activation of the NADPH oxidase. (Assari et al., 2006) 
 
Because the phagocytic NADPH oxidase and ROS production plays an important 
role in host defense against microbial pathogens, it is clear that mutations in genes 
of this enzyme lead to dramatic effects. One such genetic disorder is the chronic 
granulomatous disease (CGD), which is associated with life-threatening bacterial 
and fungal infections and is characterized by an absence of ROS production due 
to a deficiency in one of the components of the NADPH oxidase (Meischl and 
Roos, 1998; Kannengiesser, 2008). Almost 30% of CGD patients suffer from a 
genetic defect in the p47
phox gene Ncf1. In addition to p47
phox the homologue NOX 
organizing protein 1 (NOXO1), which is an analogue of p47
phox, was discovered by 
different groups (Banfi, 2003; Takeya, 2003; Geiszt, 2003).  
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2.7.2 p47
phox in autoimmune diseases 
A connection between a lack of ROS production by NADPH oxidase and 
increased autoimmunity and severity of RA in mice and rats was proposed 
(Olofsson, 2003; Gelderman, 2007). A similar effect on RA was demonstrated in a 
mouse strain with a mutation affecting splicing of the p47
phox gene Ncf1 leading to 
a defect in the oxidative burst response mediated by the NADPH oxidase complex 
(Hultqvist, 2004). In some CGD patients along with the progression of the disease 
inflammation of the gastrointestinal tract (gut) develops. Especially in CGD 
patients with a p47
phox defect these gut inflammatory processes are characterized 
as chronic IBD such as Crohn’s disease or colitis (Roos, 2006). Because the 
symptoms of CGD are typical for inflammatory processes in patients with an 
established IBD sometimes a diagnosis of CGD is difficult and confirmed only late 
(Huang, 2004).  
 
2.7.3 p47
phox in TLR signaling 
Although the evidence for a connection of p47
phox with the TLR signaling pathway 
was only circumstantial at the beginning of this study, there are some hints for a 
potential role of p47
phox along TLR signaling. Recently it was shown that IRAK4 is 
able to phosphorylate p47
phox. Interestingly, unlike protein kinase C (PKC) IRAK4 
not only phosphorylates serine residues but also threonine residues of the p47
phox 
protein (Pacquelet, 2007). Since IRAK4 is strongly involved in the signal cascades 
of TLRs we wondered whether alternative phosphorylation of p47
phox, different 
from PKC, may point to an important role of p47
phox (Kim, 2007). This could have 
an effect not only for NADPH oxidase activation, but also on the modulation of 
TLR downstream signaling. Another hint towards a link between p47
phox and the 
TLR pathways was suggested by Takeshita et al. as they discovered an 
interaction between TRAF4 and the TLR signaling molecules TRAF6, TRIF and 
IRAK1 (Takeshita, 2005). Results from yeast two-hybrid screening indicated that 
TRAF4 was able to physically form a complex with TRAF6 and p47
phox. 
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2.8 Vitamin D3 
VD3 is a steroid hormone that regulates several cellular and physiological 
responses. Furthermore VD3 is known to possess a variety of immunomodulatory 
properties including effects on both myeloid and lymphoid cells (Manolagas, 
1990). The influence of VD3 on T lymphocytes is studied extensively. Th1 
proliferation and cytokine production is inhibited by VD3 (Bhalla, 1984; Lemire, 
1992; Mattner, 2000; Boonstra, 2001). In contrast to Th1 response the effect of 
VD3 on Th2 response is controversial. Whereas it is proposed that VD3 
upregulates the Th2 cytokines IL-4 and IL-5 (van Etten, 2005) in earlier studies 
other groups showed an inhibition of the Th2 response (Cantorna, 1998; Staeva-
Vieira, 2002). Furthermore VD3 inhibits IL-6, an important cytokine for the 
differentiation of Th17 cells (Xue, 2002). In addition to the T lymphocytes also the 
differentiation and maturation of monocytes and DCs are influenced by VD3 which 
interfere with the activation of T lymphocytes (Abe, 1981; Kreutz, 1990; 
Schwende, 1996; Berer, 2000; Penna, 2000; Griffin, 2001). Although in 
macrophages phagocytosis and bacterial killing is stimulated by VD3 treatment the 
antigen-presenting capacity is suppressed i.e. by the inhibition of MHC-II 
expression (Lemire, 1992; Griffin, 2000). During differentiation of monocytes into 
macrophages VD3 stimulates the phagocytosis by upregulation of NADPH oxidase 
activity which is mediated by an increased p47
phox expression and its translocation 
to the membrane (Fuhrman, 2004). This correlates with an enhanced 
antimycobacterial activity of monocytes treated with VD3 (Sly, 2001). The 
discovery of the VD receptor (VDR) led to a better understanding of these 
immunomodulatory effects of VD3. VDR is a member of the nuclear hormone 
receptor superfamily and apart from its role for calcium and phosphate 
homeostasis it has been identified in mononuclear cells, DCs, APCs and activated 
T and B lymphocytes (Arnson, 2007). Additionally, in primary lymphoid organs 
such as BM and thymus VDR expression has been approved (Deluca, 2001; 
Langub, 2000). 
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2.9 Objectives 
In many immune disorders such as autoimmunity, chronic inflammatory diseases 
and cancer cytokines play an important role. Although it is well accepted that most 
of these disorders are strongly affected by the adaptive immunity including T and 
B cells, in the last years the role of DC more and more shifted into the focus of 
research.  
In this thesis differences in the regulation of the IL-12 family members IL-12p70 
and IL-23 through exogenous and endogenous factors should be investigated. A 
variety of DC subtypes exist and their potential to produce cytokines differs 
between them. In the experiments planned DCs from different immune organs 
have to be investigated. Some DCs produce only one of the both selected 
cytokines. DCs from the skin, iLCs, only produce IL-23 whereas in contrast splenic 
cDCs are characterized by their exclusive IL-12p70 secretion. As a model for DCs 
capable to secrete both cytokines BM cells, expanded and differentiated into DCs, 
will be used in several experiments. 
In the following the influence of three different factors on the expression and 
secretion of either IL-12p70 or IL-23 will be investigated. Therefore this thesis is 
divided into three major chapters: 
 
1.  Regulation of IL-23 by Selenium  
To investigate the role of inorganic Selenium on the IL-23 secretion of the iLC line 
XS-52 in different experiments cells will be cultured with and without Selenium, 
incubated with different stimuli to induce the cytokine production and finally 
analyzed. As an iLC-specific read-out levels of IL-23 are determined. In addition to 
the heterodimeric protein IL-23 that is secreted into the supernatant, also 
measurements of its subunits p19 and p40 on mRNA and protein level will be 
presented.  
2. Regulation of IL-12p70 and IL-23 by p47
phox 
Based on the finding that p47
phox deficiency is associated with autoimmune 
diseases in mice and rats we asked the question, whether p47
phox may also have a 
function in addition to that within the NADPH oxidase complex? To address this 2 Introduction    Richter 
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question published data were collected that raised evidence towards a role of 
p47
phox in the TLR signaling pathway. Although rare, some interesting hints in 
these investigations convinced us to analyze the influence of p47
phox for the TLR-
dependent IL-12p70 and IL-23 production. Therefore different mouse and rat 
models with different p47
phox mutations were planned to use for in vitro and in vivo 
investigations. For in vitro studies DCs from different immune organs should be 
isolated and the cytokine production upon TLR stimulation has to be measured. 
Furthermore the ROS level of p47
phox deficient and wild type (WT) mice have to be 
cosidered. Based on these in vitro results indicating the innate immune response 
of DCs in vivo experiments investigating the effects on the adaptive immunity have 
been planned to follow. 
3. Role of Vitamin D3 on IL-12p70 expression  
Because VD3 exhibits immunomodulatory properties such as the inhibition of T cell 
differentiation or antigen-presenting capacity of DCs in this study the direct 
influence of VD3 on the cytokine production of DCs should be determined. In 
several experiments with different mouse strains the VD3 influence on IL-12p70 
secretion should be detected. Finally a possible connection between VD3 and 
p47
phox should be tested. Therefore experiments with p47
phox deficient and WT 
mice have to be performed. 
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3 MATERIAL AND METHODS 
3.1 Mouse and rat strains 
3.1.1 C57BL/6 strain 
The C57BL/6 strain is one of the most common inbred mouse strains. Because the 
C57BL/6 strain is very robust and relatively easy to breed they are widely used as 
genetic background for genetically modified mice which were developed as 
models of human diseases. It is well known that the C57BL/6 strain is biased 
towards Th1 response and furthermore characterized by the activation of type-I 
macrophages (Mills, 2000). C57BL/6 strains are i.e. resistant to the intracellular 
pathogen  Leishmania major, whereas the BALB/c strain is susceptible for the 
infection (Mills, 2000). For our experiments C57BL/6 mice were obtained from 
Harlan Winkelmann GmbH (Borchen, Germany). 
 
3.1.2 BALB/c strain 
In contrast to the C57BL/6 strain is the BALB/c mouse characterized by a typical 
Th2 response including the activation of type-II macrophages. They were mainly 
used for cancer and immunology research. Since 1920 the original colony was 
systematically inbred by several laboratories and new BALB/c substrains has been 
developed. The most substrains reach over 200 generations to date. BALB/c mice 
for our studies were purchased from Harlan Winkelmann GmbH (Borchen, 
Germany). 
 
3.1.3 p47
phox-/- mice 
CGD is a rare genetic disease in which phagocytes do not produce oxidative 
metabolites such as hydroxyl radical, superoxide, hydrogen peroxide and 
hypochlorous acid which are important for the host defence. Mutations in the 
different components of the NADPH oxidase are known as causes for the disease. 
The most common form is the X-linked form of CGD characterized by mutations in 
the membrane-bound gp91
phox (60% of cases), followed by autosomal recessive 
forms caused by mutations in p47
phox (30% of cases), p67
phox (5% of cases) and 
p22
phox (5% of cases). CGD patients suffer from severe bacterial and fungal 3 Material and Methods    Richter 
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infections combined with aberrant inflammatory responses and tissue granuloma 
formation (Meischl and Roos, 1998; Kannengiesser, 2008). 
The first mouse model for CGD with a mutated p47
phox was generated by Steven 
M. Holland (Jackson Laboratory, Bar Harbor, Maine, USA). The p47
phox gene was 
disrupted by the insertion of a neomycin cassette into exon 7 (Jackson, 1995). 
Those p47
phox-/- mice were backcrossed to the C57BL/6 background and bred at 
the local animal facility under specific pathogen-free conditions. 
For our in vivo experiments we also used p47
phox-/- mice with a neomycin cassette 
in exon 3, produced by Jürgen Roes (Harbord, 2002). Those mice, backcrossed to 
C57BL/6 for ten generations, were kindly provided by A.M. Shah (Li, 2003).  
 
3.1.2 Natural mutated p47
phox mice 
Additional to the generated p47
phox-/- mouse models we used an earlier identified 
mouse strain with a natural mutation in the p47
phox gene (Huang, 2000). This 
mutation, located at a splicing site of exon 8 of the p47
phox gene, results in different 
splice transcripts. Consequently those truncated proteins influence the NADPH 
oxidase function, resulting in the loss of ROS production. Mice were backcrossed 
to B10.Q strain by Rikard Holmdahl and signed as Ncf1
*/* (Karolinska Institutet, 
Stockholm, Sweden).  
 
3.1.3 gp91
phox-/- mice 
As a model for the X-linked form of CGD gp91
phox knockout mice were generated 
by insertion of a neomycin cassette in exon 3 (Pollock, 1995).  Comparable to the 
p47
phox-/- mice gp91
phox knockouts are characterized by an absent ROS production. 
For our experiments we obtained the gp91
phox-/- mice from the Jackson Laboratory 
(Bar Harbor, Maine, USA). 
 
3.1.4 TRIF
-/- mice 
TRIF
-/- mice were generated by initiation of a program for random germline 
mutagenesis, resulted in a single base-pair deletion in the TRIF gene (Hoebe, 
2003). Consequently 24 amino acids have been removed from the carboxy 
terminus. Due to this mutation the TRIF-dependent TLR signaling is impaired. The 3 Material and Methods    Richter 
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TRIF
-/- mice were kindly provided by U. Kalinke and Z. Waibler (PEI, Langen) with 
the consent of B. Beutler (Scripps Research Institute, La Jolla, USA). 
 
3.1.5 MyD88
-/- mice 
MyD88 is the adaptor protein for both pathways, TLR4 and TLR9. In 1998 a 
MyD88 knockout mouse was created. The knockout of the MyD88 gene was 
generated by the replacement of 2 exons with a neomycin cassette (Adachi, 
1998). Those mice show an impaired IL-1β and IL-18 signaling. We also obtained 
the MyD88
-/- mice from the PEI with the consent of S. Akira (Osaka University, 
Osaka, Japan). 
 
3.1.6 p47
phox mutated rats 
Investigating the human rheumatoid arthritis different models for mice and rats 
were established. Pristane induced arthritis (PIA) sudden and strong developed in 
the highly susceptible DA rats, but not in the E3 rats. Polymorphisms in arthritis-
linked gene loci were investigated in both strains and two polymorphisms resulting 
in amino acid substitutions were identified (Olofsson, 2003). Only one 
polymorphism of both, at position 153 resulted in complete protection to RA in E3 
rats (153Thr) and high susceptibility in DA rats (153Met), respectively. This 
fragment from the E3 allele was transferred onto the DA background to obtain a 
congenic strain. Excluding interference from other E3 loci this congenic strain was 
backcrossed with DA rats for 12 generations. The backcrossed strain DA.Ncf1.
E3 is 
completely protected to RA whereas the “wildtype” DA.Ncf1.
DA  are highly 
susceptible to RA.  
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3.2 Methods of cell biology 
3.2.1 Cultivation and stimulation of the immature Langerhans cell line XS-52 
 
XS-52 medium:     Iscove’s medium 
2 mM L-glutamine  
100 IU/ml Penicillin 
100 µg/ml Streptomycin  
1 mM sodium pyruvate 
100 µM non-essential amino acids 
50 µM β-ME 
 
The immature Langerhans cell line XS-52 was established by Xu et al. (Xu, 1995). 
Therefore cells were isolated from epidermis of newborn BALB/c mice and 
cultivated in vitro for several month in RPMI medium supplemented with 10% of 
keratinocyte supernatant and 5 ng/ml GM-CSF. 
In our lab iLCs were plated at density of 2.5x10
6 in 10ml medium supplemented 
with 5% FCS. Additionally cells were cultivated with GM-CSF (5ng/ml) and 
passaged once a week. In all experiments with iLCs cells were plated 2.5x10
6 in 
10ml medium supplemented with 5% FCS and cultivated for 3 days. For the 
Selenium experiments iLCs were cultivated in medium containing Na2SeO3 in 
different concentrations (defined in the respective experiments). Afterwards cells 
were centrifuged and cultivated in serumfree medium for 24 hrs. Next day cells 
were stimulated with different TLR ligands and/or IFN-γ for 24 hrs.  
 
3.2.2 Isolation of primary cells from spleen and lymph nodes 
 
ACK buffer:       0.15 M NH4Cl 
10 mM KHC03 
0.1 mM Na2EDTA 
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Spleen cell medium:    Iscove’s medium 
2 mM L-glutamine  
100 IU/ml Penicillin 
100 µg/ml Streptomycin  
1 mM sodium pyruvate 
100 µM non-essential amino acids 
50 µM β-ME 
 
Lymph node cell medium:   RPMI 1640 with Glutamax 
100 IU/ml Penicillin 
100 µg/ml Streptomycin  
100 µM non-essential amino acids 
 
Whole spleens or lymph nodes were dissected from mice and stored in PBS or 
medium without FCS until further processing. Spleens were gently homogenized 
with a glass tissue homogenizer. In contrast lymph nodes were homogenized 
using a cell strainer and the back of a plastic syringe. After rinsing the 
homogenizer or cell strainer thoroughly cell suspensions were centrifuged 
(1500rpm) for 10 min at room temperature. For removal of red blood cells pellets 
were suspended in ACK buffer and incubated for 3 min at 37°C. Blocking the 
reaction 2 volumes of medium with 5% FCS was added. Finally cell suspension 
was washed twice with serumfree medium and cells were counted.  
 
3.2.3 Purification of CD11c
+ dendritic cells from the spleen 
 
Collagenase D buffer:  100 mg Collagenase D 
    1 0   m M   H E P E S  
    0.15  M  NaCl 
    5   m M   K C l  
    1  mM  MgCl2 
    1 . 8   m M   C a C l  
ad 50 ml H2O (molecular grade) 
sterile filtered trough a 0.22 µm filter unit 
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MACS  buffer:    PBS   
0.5% BSA 
2 mM EDTA 
 
Spleen cells were prepared by enzymatic disaggregation using Collagenase D 
buffer (Roche Diagnostics, Mannheim). Spleens were cut into small pieces and 
disrupted using a cell strainer. Cells were suspended in MACS buffer. 
Subsequently spleen cells were magnetically labeled with CD11c MicroBeads 
(Miltenyi, Bergisch Gladbach), incubated and separated using a magnetic field 
according to the manufacture’s protocol. Cells from positive and negative fraction 
were count for further processing. Purity of the CD11c positive fraction was 
determined by FACS analysis. 
 
3.2.4 Isolation and differentiation of BM-derived cells 
 
BM cell medium:     RPMI 1640 with Glutamax 
100 IU/ml Penicillin 
100 µg/ml Streptomycin  
1 mM sodium pyruvate 
1/100 HEPES 
50 µM β-ME 
 
In the murine system BM cells were isolated from Femur and Tibia. Therefore 
mice were sacrificed and complete bones were dissected. Femur and Tibia were 
separated and both ends of each bone were cut. With a syringe filled with PBS the 
BM was flushed out into a dish until bones got white and clear. The BM was 
suspended with PBS and centrifuged (1100rpm) for 6 min at RT. Cell pellet was 
suspended with ACK buffer for red blood cell lyses and incubated at RT for 1 min. 
Reaction was blocked with medium with 10% FCS. Cell suspension was 
centrifuged as described above. The cell pellet was suspended with fresh medium 
containing 10% FCS and cell number was determined. 
For the differentiation of BM cells into DCs two well established protocols are 
generally used (Waibler, 2007). pDCs were generated with 100 ng/ml murine Flt3-3 Material and Methods    Richter 
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L whereas mDCs require 100 ng/ml murine GM-CSF for their differentiation. 
Freshly isolated BM cells were seeded 2x10
6/ ml in the presence of Flt3-L to 
differentiate into pDCs. In contrast 10
6 BM cells per ml were incubated with GM-
CSF for 7 days to generate myeloid DCs. After 4 days two-thirds of medium was 
exchanged and Flt3-L and GM-CSF, respectively were added.  
 
3.2.5 Cultivation and stimulation of primary and BM-derived, differentiated 
cells 
Primary spleen cells were seeded at 3x10
6 cells/ ml in T25 cell culture flasks with 
medium supplemented with 5% FCS and cultivated over night in a humidified 
incubator (5% CO2 and 37°C). Next day medium was changed to serumfree 
medium and cells were stimulated with TLR ligands for 20 hrs. TLR4 was 
stimulated with 1 µg/ml LPS (Sigma Aldrich, Seelze, Germany) and TLR9 with 2.5 
µM CpG ODN2216, CpG ODN2088 and GpC ODN2216 (InvivoGen, Toulouse, 
France), respectively. Other stimulations were defined in the respective 
experiments. 
Purified CD11c
+ cells were seeded in 6-well plates (10
6 cells/ ml) in medium with 
5% FCS and incubated over night. Next day cells were stimulated in serumfree 
medium as described above. 
BM-derived, in vitro differentiated DCs were seeded in serumfree medium (10
6 
cells/ ml) and directly stimulated with TLR ligands. After 20 hrs supernatant was 
collected and cytosolic protein or mRNA were isolated.   
 
3.2.6 FACS analyses 
 
FACS  buffer:    PBS 
    1 %   F C S  
    1 %   N a N 3 
 
 
Original spleen cells, magnetically separated CD11c positive and negative cells 
were stained for CD11c surface expression with anti-CD11c antibody. Dendritic 
cells differentiated from BM cells were measured for their typical CD markers 
(Table 2). Fluorescence labeled antibodies were used for the detection are listed 3 Material and Methods    Richter 
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in the table below. Isotype controls were used as controls. Subsequently cells 
were washed twice with FACS buffer and fixed with 1% paraformaldehyde. 
Expression of CD11c was detected with FACSCalibur Flow Cytometer (BD) and 
evaluated with CellFlow software. 
 
Table 4: Antibodies and Isotyp controls for FACS analysis 
antigen fluorescence  dye  company 
CD11c Allophycocyanin  (APC)  Miltenyi, Bergisch Gladbach 
Hamster IgG  Allophycocyanin (APC)  BD Bioscience, Heidelberg  
B220  Fluorescein isothiocyanate  (FITC)  Miltenyi, Bergisch Gladbach 
Rat IgG2A  Fluorescein isothiocyanate  (FITC)  AbD serotec, Oxford, UK 
 
3.2.7 Concentration of the supernatant  
Following incubation with different stimuli cells were scraped and centrifuged 
(1500rpm) for 10 min at 4°C. Cell-free supernatants were concentrated six-fold 
with 10 kD Centriprep columns by centrifugation (3000rpm) for 45 min at 4°C 
(Millipore, Schwalbach, Germany). Centripreps were equilibrated with H2O (Gibco) 
and centrifuged (3000rpm) for 8 min before use. 
 
3.2.8 Protein isolation from whole cells 
During all isolation steps samples were kept at 4°C. Cell pellets were suspended 
in PBS containing phosphatase inhibitor cocktail. Subsequent cell suspension was 
sonified on ice for cells lyses. After sonification the detergent Nonidet P-40 (1:16) 
and 10mM HEPES were added and suspension was kept on ice for 15 min. 
Following suspension was centrifuged (3000rpm) for 10 min. The pellet contains 
the nuclear fraction whereas the supernatant contains membrane and cytosolic 
proteins.  
 
3.2.9 Protein assays 
Protein concentrations of the supernatant and the cytosol/membrane fraction were 
quantitatively determined with BCA assay (Pierce, Rockford, IL). Samples were 
diluted in H2O and incubated with BCA reagent in a 96-well plate at 37°C. With a 3 Material and Methods    Richter 
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more sensitive protocol, micro BCA, very low protein concentrations were 
detectable. Standard curves were created with BSA. 
 
3.3.10 Detection of Reactive Oxygen Species (ROS) 
 
Reaction buffer:    10 mM HEPES 
    Tyrode’s  salt   
    adjusted  to  pH  7.4  at  37°C   
 
In spleen cells ROS production of cells was stimulated with 100nM PMA (Alexis 
Biochemicals) and inhibited using 5 µM DPI (diphenylene iodonium chloride) from 
Sigma Aldrich. H2O2 release of spleen cells was measured fluorometrically with 
Amplex Red reagent purchased from Molecular Probes (Paisley, UK). The Amplex 
Red reagent in combination with horseradish peroxidase (Sigma Aldrich, Seelze, 
Germany) reacts with H2O2 in a 1:1 stochiometrically to produce resorufin 
(oxidation product). In the experimental setting spleen cells were isolated and 
stimulated with LPS, CpG2216 or left untreated for a 20 h period as described 
before. Subsequently 5x10
5  spleen cells were seeded in 96-well plates in 200 
µl/well reaction buffer containing Amplex Red and horseradish peroxidase (HRP). 
ROS release of seeded cells was measured continuously from the start and, after 
the addition of PMA at 35 min, performed for a total period of 75 min. 
 
3.3 Immunological methods 
3.3.1 SDS PAGE 
 
Resolving Gel (12.5%)  3.4 ml H2O 
    2.5  ml  TRIS  (1.5M,  pH  8.8) 
    4.1  ml  Polyacrylamide 
    0.1  ml  SDS  (10%) 
    0.1  ml  APS  (10%)      
    4   µ l   T E M E D  
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Stacking Gel (5%)    1.4 ml H2O 
        0.25 ml TRIS (1.5M, pH 6.8) 
    0.33  ml  Polyacrylamide 
    20  µl  SDS  (10%) 
    20  µl  APS  (10%)      
    2   µ l   T E M E D  
 
Proteins of whole cell lysates were separated by SDS PAGE. SDS polyacrylamid 
gels were prepared in two steps. First the resolving gel was prepared, cast and 
covered with isopropanol. After polymerization isopropanol was decanted and the 
gel was rinsed twice with H2O and dried with paper. The stacking gel was 
prepared, cast over the resolving gel and combs were adopted. Protein samples 
were mixed with loading dye containing β-mercaptoethanol to generate reducing 
conditions. Afterwards samples were boiled for 5 min and loaded on the gel. 
Finally Gel was into SDS buffer and electric current was applied (0.04-0.08 A). 
After 1-1.5 hrs depending on the size of the favored proteins and the current 
applied gel was blotted (3.3.2). 
 
3.3.2 Western Blot 
 
Blotting buffer A:    0.3 M Tris 
    20%  Methanol 
    Adjusted  to  pH  10.4 
 
Blotting buffer B:    25 mM Tris 
    20%  Methanol 
Adjusted to pH 10.4 
 
Blotting buffer C:    25 mM Tris 
      0 . 0 4   M   ε-amino-n-capronacid 
      20%  Methanol 
Adjusted to pH 9.4 
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Wash buffer 1 (PBST):  PBS 
    0.05%  Tween20 
    Adjusted  to  pH  7.5 
 
Wash buffer 2 (TBST):  100mM Tris 
    0.15  M  NaCl 
    0.05%  Tween20 
           Adjusted  to  pH  7.5   
 
Table 5: Antibodies for Western Blot 
protein primary  antibody  secondary  antibody 
p19  goat anti-p19 (R&D)  rabbit anti-goat HRP (Dako) 
p40  BAF499 (R&D)  Streptavidin-HRP (R&D) 
 
Gels from SDS-PAGE were blotted on a PVDF membrane. Therefore filter papers 
were soaked in buffer A, B and C, respectively. In defined order filter papers, gel 
and PVDF membrane were stacked into the blotting apparatus (Fig. 2). It is 
important to avoid air between the several layers. Blotting apparatus was closed 
and electric current (0.08-0.12 A) was applied for 45-60 min, depending on the 
number of gels. Afterwards blots were washed in wash buffer 1 and 2, respectively 
for 15 min. For detection of p19 protein blots were blocked for 1 hr with 3% non-fat 
dried milk in PBST, for p40 protein with 1% BSA in PBST. Blots for p47
phox 
detection were blocked with 5% non-fat dried milk in PBST. Blots were washed 
again with wash buffer. Afterwards blots were incubated with the respective 
antibodies over night. Next day blots were washed and stained with their 
corresponding secondary antibodies for 1-1.5 hrs. After a further wash step blots 
were incubated 1 min with ECL reagent and developed with hyperfilms 
(Amersham). Confirm the constant loading of gels with proteins blots were stripped 
with stripping buffer for 20 min at 37°C and stained for β-actin with the respective 
antibody.  
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Fig. 3: Assembly of the blotting apparatus 
 
3.3.3 Enzyme-linked immunosorbent assay 
 
ELISA wash buffer:    PBS 
    0.05%  Tween20 
 
 
Cytokines of interest were measured in the supernatant. Therefore mouse specific 
ELISA assays for detection of IL-12p70 (eBiosciences), IL-10 (R&D Systems) and 
IFN-α (PBL Biomedical Laboratories) were used. Except for the IFN-α ELISA 
96well plates were pre-coated with the capture antibody and incubated over night 
at 4°C. In the IFN-α ELISA kit plates are already pre-coated with antibody. Next 
day plates were blocked with blocking buffer, washed 3 times and samples and 
standard dilutions respectively were pipette into the wells. After 1.5-2 hrs plates 
were washed again and detection antibodies were incubated for 2 hrs. Finally 
antibody-coupled enzymes were used and substrates were pipette. Enzyme-
substrate reaction was stopped with H2SO4 and plates were measured at 450nm. 
Results were standardized with standard curves and normalized to whole cell 
protein measured by BCA protein assay. 
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3.3.4 ELISPOT assay 
ELISPOT assays were performed as described (Radeke, 2002): in brief, ELISPOT 
plates (Millipore, Schwalbach, Germany) were coated with capture antibody for 
murine IFN-γ (BD, Heidelberg, Germany) overnight at 4°C. Plates were then 
washed and blocked with 1% cell culture-grade BSA/PBS for 1 hr at room 
temperature. After washing freshly isolated lymph node cells were seeded at 
3x10
5/ well or spleen cells at 5x10
5/well in RPMI medium (Gibco, Invitrogen, 
Karlsruhe, Germany), supplemented with 100 IU/ml penicillin, 100 µg/ml 
streptomycin, 100 µM non-essential amino acids and 10% fetal calf serum. Cells 
were stimulated with or without 13.5 µg/ml ovalbumin and cultured for 24 hrs at 
37°C. Thereafter cells were removed and plates were washed with PBS and 
PBS/Tween. Detection antibody for mIFN-γ (BD, Heidelberg, Germany) was added 
in 1%BSA/PBST and incubated overnight. Plates were washed with PBST and 
PBS before developing the colorimetric assay by addition of 3-amino-9-
ethylencarbazole/DMF in 0.1 M sodium acetate buffer (1:30). Colorimetric reaction 
was stopped with distilled water and air dried. ELISPOT plates were subjected to 
the computerized ELISPOT reader system A.EL.VIS (ELI.Scan) and enumerated 
with the ELI.Analyse Software V5.0 (A.EL.VIS GmbH, Hannover, Germany). 
 
3.4 Molecular biological methods 
3.4.1 Isolation of mRNA 
Cellular mRNA was isolated with the RNeasy Mini Kit (Qiagen). For cell lyses 
pellets were suspended in RLT buffer containing β-mercaptoethanol. Cell lysates 
were homogenized using QiaShredder columns (Qiagen). Homogenates were 
mixed with 1 volume EtOH and loaded onto RNeasy columns and centrifuged 
(12000rpm) for 2 min. Columns with bound mRNA were washed with RW1 and 
RPE buffer and centrifuged in between. Finally columns were dried by 
centrifugation and mRNA was eluated with H2O (molecular grade). Concentration 
of RNA was determined photometrically by using an UV Spectrometer (260 nm). 
Purity was measured by the ratio RNA to protein (260/280 nm). 
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3.4.2 cDNA synthesis 
 
Primer Mix (10µl):    2 µg mRNA 
1 µl Oligo(dT)n 
    1  µl  Random  Hexamers 
    8   µ l   H 2O (molecular grade) 
 
Mastermix (10µl):    4 µl 5x cDNA Synthase buffer 
    1  µl  0.1  M  DTT 
    1   µ l   H 2O (molecular grade) 
    2  µl  10  mM  dNTP  Mix 
    1   µ l   R N A s e   O u t  
    1   µ l   R T  
 
First strand cDNA synthesis was performed using the ThermoScript RT-PCR 
system (Invitrogen). Primer Mix and 2 µg of mRNA sample were mixed and 
denatured for 5 min at 65°C. Afterwards 10 µl of Mastermix were pipette to the 
samples and the following program applied. 
 
Table 6: RT-PCR program 
Temperature Time 
25°C 10  min 
50°C 45  min 
85°C 5  min 
 
Finally samples were incubated with 1 µl RNAse H for 20 min at 37°C.     
 
3.4.4 Standard PCR 
 
PCR Mastermix:  5 µl 10x PCR buffer 
   1.5  µl  MgCl2 
   1  µl  dNTPs 
   3 8   µ l   H 2O (molecular grade) 
      1 µl forward primer (10 µM) 
      1 µl reverse primer (10 µM) 
   0.5  µl  Taq-polymerase 3 Material and Methods    Richter 
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For the PCR 48 µl mastermix and 2 µl cDNA sample were mixed in a PCR tube 
and centrifuged to avoid air bubbles in the sample. For cDNA product amplification 
of p19 and p40, subunits of IL-23, specific forward and reverse primers were used. 
As a control for the same amount of cDNA in the reaction the house keeping 
cDNA of GAPDH was also analyzed. 
 
Table 7: Primer sequences (MWG Biotech) 
Primer Sequence 
p19 forward  CAGCAGCTCTCTCGGAAT 
p19 reverse  ACAACCATCTTCACACTGGATACG 
p40 forward  TCTTTGTTCGAATCCAGCG 
p40 reverse  GAAAACTGGAAAAAGCCAACC 
GAPDH forward  ACCACAGTCCATGCCATCAC 
GAPDH reverse  TCCACCACCCTGTTGCTGTA 
 
 
Afterwards PCR was performed with the following standard program, whereas the 
annealing temperature depends on the melting temperature of the primer.  
 
Table 8: Standard PCR program 
Temperature Time  Step 
94°C  2 min  activation of the 
Taq polymerase
94°C 1  min  Denaturation 
60°C 1  min  Annealing 
72°C 2  min  Elongation 
72°C  10 min  Final elongation 
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3.4.3 Real time PCR 
 
Table 9: Primer sequences (MWG Biotech) 
Primer Sequence 
p19 forward  5’ TGCTGGATTGCAGAGCAGTAA 
p19 reverse  5’ GCATGCAGAGATTCCGAGAGA 
p19 probe  5’ TATGGCTGTTGCCCTGGGTCACTCA 
p35 forward  5’ CCACCCTTGCCCTCCTAAAC 
p35 reverse  5’ GTTTTTCTCTGGCCGTCTTCA 
p35 probe  5’ CCTCAGTTTGGCCAGGGTCATTCCA 
p40 forward  5’ GGAAGCACGGCAGCAGAATA 
p40 reverse  5’ AACTTGAGGGAGAAGTAGGAATGG 
p40 probe  5’ CATCATCAAACCAGACCCGCCCAA 
18s forward  5’ GAAACGGCTACCACATCCAAG 
18s reverse  5’ CGGGTCGGGAGTGGGT 
18s probe  5’ AAGGCAGCAGGCGCGCAAA 
 
Primers (1 µM) and fluorogenic probes (1 µM; labeled with 5’ FAM and 3’ TAMRA) 
for murine p19, p35, p40 and 18s were purchased from Thermo Fisher Scientific 
(Ulm, Germany). Real Time PCRs were performed in duplicates with 2.5 µl of 
cDNA and 0.5 µl forward primer, 0.5 µl reverse primer, 0.5 µl probe, 8.5 µl distilled 
water and 12.5 µl Platinum Quantitative PCR SuperMix-UDG (Invitrogen) with the 
following cycling program (45 cycles). 
 
Table 10: Real Time PCR program 
Temperature Time  Step 
50°C  2 min  activation of the 
Taq polymerase 95°C 2  min 
95°C 15  sec 
amplification 
60°C 45  sec 
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3.4.4 Polyacrylamidgel-electrophoresis 
 
Polyacryamidgel:    0.2 ml 50x TAE buffer 
    4.0  ml  Polyacrylamid 
    5 . 8   m l   H 2O 
    0.1  ml  APS  (10%) 
             4   µ l   T E M E D  
 
    50x TAE buffer:    2 M Tris acetate 
      50  mM  EDTA,  pH  8.0 
 
Gel was prepared, poured between 2 glass plates and a comb was inserted. After 
polymerization of the gel the comb was removed and 10 µl PCR sample mixed 
with 2 µl 6x loading dye was loaded onto the gel. Subsequently 1x TAE buffer was 
filled into the tray containing the loaded gel and was run at 100-120 V for 1 hr. To 
enables the analysis of DNA fragment size in the sample a molecular-weight 
marker was included.   
 
3.5 In vivo immunization 
Referring to classical protocols described to elicit delayed-type hypersensitivity 
three groups of five mice were injected s.c. at the base of the tail at 7-9 week of 
age. OVA (Sigma Aldrich, Seelze, Germany) alone or with CpG2216 (InvivoGen, 
Toulouse, France) and PBS alone as a control, respectively, were mixed with 
Incomplete Freund’s Adjuvant (IFA; Sigma Aldrich, Seelze, Germany) at a 1:1 ratio 
and emulsified. All mice received injections of 200 µl emulsion each either with 50 
µg OVA /mouse, with a combination of 50 µg OVA and 50 µg ODN2216 /mouse, 
or with PBS in IFA, and were sacrificed after 10 days. Inguinal and axillary lymph 
nodes were isolated and single lymphocyte suspensions used for ELISPOT 
analysis. 
 
 
 
 
 4 Results    Richter 
41 
 
4 RESULTS 
 
4.1 Regulation of IL-23 by Selenium 
In this study we investigated the effect of Selenium (sodium selenite, Na2SeO3) on 
the expression of IL-23 subunits (mRNA and protein level) and secretion of the 
bioactive heterodimer in iLCs that following stimulation exclusively produced IL-23 
but no IL-12p70. 
  
4.1.1 Regulation of IL-23 by different TLR ligands in combination with 
Selenium 
In the initial experiments of this study iLCs were cultivated in medium 
supplemented with different concentrations of Selenium (50, 100, 250 nM) or left 
untreated for 1-2 weeks. Following iLCs were stimulated with different TLR ligands 
for 24 hrs. Finally IL-23 secretion was measured in the supernatant. We detected 
an increased IL-23 secretion upon TLR4 stimulation with LPS and a further up-
regulation with Selenium treatment dose dependently. TLR9 and TLR 7/8 
stimulation with CpG2216 and R848, respectively resulted in IL-23 secretion, but 
was not further influenced by Selenium treatment. Cells stimulated with TLR5 
ligand Flagellin did not secrete IL-23 (Fig. 4). 
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Fig. 4: IL-23 secretion upon TLR stimulation and Selenium treatment. 
Selenium treated iLCs were further stimulated with TLR ligands. TLR4 stimulation with 
LPS [1 µg/ml] resulted in enhanced IL-23 secretion that was additional dose dependently 
increased by Selenium. Stimulation with CpG2216 [2.5 µM] and R848 [5 µM] increased IL-
23 secretion, but no further up-regulation was detectable when cells were treated with 
Selenium. TLR5 ligand Flagellin [50 ng/ml] did not induce IL-23 production.   
 
 
4.1.2 Regulation of IL-23 subunits p19 and p40 by Selenium 
Since we have measured an up-regulation of IL-23 by Selenium supplementation 
we wanted to know whether both subunits of the heterodimer IL-23, p19 and p40 
are directly influenced. First we cultured iLCs 1-2 weeks with medium containing 
Selenium (250 nM) and pure medium, respectively. Following iLCs were 
stimulated with TLR4 ligand LPS or IFN-γ or a combination of both and incubated 
for 24 hrs. Finally mRNA was isolated, measured and cDNA was synthesized with 
RT-PCR. Whereas p19 mRNA was constitutively expressed, p40 mRNA was 
induced by LPS and furthermore enhanced by treatment with Selenium (Fig. 5). 
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Fig. 5: mRNA expression of p19 and p40. 
iLCs, treated with Selenium were stimulated with LPS [1 µg/ml] and IFN-γ [10 ng/ml] and 
mRNA expression of both subunits p19 and p40 was measured by standard PCR. p19 
mRNA was constitutively expressed and not up-regulated by LPS or Selenium treatment. 
In contrast p40 mRNA was induced by LPS and further up-regulated by Selenium. 
 
 
From mRNA results we were further interested in the protein levels of both IL-23 
subunits. Therefore LPS and IFN-γ stimulated and Selenium treated iLCs were 
centrifuged and supernatant was concentrated 6-fold. With Western Blot analysis 
and specific antibodies we detected secreted monomers p19 and p40 in the 
supernatant. Whereas p19 mRNA was constitutively expressed the protein was 
initially translated upon LPS stimulation (Fig. 6a). Additional stimulation with IFN-γ 
decreases p19 protein, whereas treatment with Selenium had no influence on p19 
protein (Fig. 6a). In contrast p40 was not decreased after IFN-γ stimulation, but in 
the presence of Selenium p40 protein was down-regulated (Fig. 6b).  
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p19 
GAPDH 
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IFN-γ        −           −         +          −           −          +
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Fig. 6: Western blot analysis of IL-23 subunits p19 and p40. 
Protein induction of p19 and p40 was measured in the supernatant from LPS and IFN-γ 
stimulated iLCs that where cultured in medium containing Selenium or left untreated. 
Whereas p19 mRNA was constitutively expressed protein was initial induced by LPS and 
inhibited by IFN-γ addition (a). In contrast p40 protein was also induced by LPS, but IFN-γ 
had no influence (b). Selenium treatment did not change the p19 protein induction (a), but 
p40 protein was increased in iLCs cultivated in Selenium-containing medium (b). 
 
 
From the mRNA data and the protein results of both IL-23 subunits we finally 
measured the IL-23 heterodimer secretion in the supernatant of those iLCs, 
treated with Selenium and stimulated with LPS and IFN-γ. As expected and known 
from the initial experiment LPS did induce IL-23 secretion (Fig. 7, gray bars). 
Furthermore this was enhanced by Selenium treatment (250nM). Additional 
stimulation with IFN-γ resulted in an inhibition of the LPS induced IL-23 secretion 
in both, Selenium-treated and untreated iLCs (Fig. 7, black bars). 
Selenium                  w/o                              250nM  
LPS         −          +          +             −           +            + 
IFN-γ         −          −            +             −           −            + 
p40 
p19  19kD - 
40kD - 
Selenium                  w/o                              250nM  
LPS         −          +          +             −           +            + 
IFN-γ         −          −            +             −           −            + 
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Fig. 7: IL-23 secretion of iLCs measured by mouse specific ELISA. 
LPS stimulated iLCs secrete IL-23 which was further enhanced by Selenium 
supplementation (gray bars). Stimulation with IFN-γ resulted in an inhibition of LPS 
induced IL-23 secretion in Selenium treated and untreated cells (black bars).  
 
In summary we found a Selenium-dependent increase of IL-23 protein in dendritic 
cells (immature Langerhans cell line). Interestingly only IL-23 subunit p40 was 
regulated by Selenium on both mRNA and protein level, p19 was unaffected. 
Stimulation with IFN-γ resulted in the reduction of LPS-induced IL-23 whereas only 
p19 protein was downregulated, not p40. In combination with Selenium treatment 
p40 protein was also diminished. 
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4.2 Regulation of IL-12p70 and IL-23 by p47
phox 
Supplementation with Selenium resulted in increased IL-23 production of iLCs. 
Since it was shown that Selenium influences the redox status of the cell and 
consequently the antioxidant activity it would be interesting whether a subunit of 
the ROS producing enzyme NADPH oxidase, p47
phox, influences the cytokine 
signaling in DCs. Based on the findings that deficiency of p47
phox resulted in an 
increased susceptibility to RA and EAE in animal models, with the following part of 
this thesis the question should be answered whether p47
phox deficiency is 
associated with an increased immune response of DCs.  
 
4.2.1 IL-12p70 regulation upon TLR stimulation in primary spleen cells 
4.2.1.1 Regulation of IL-12p70 in p47
phox knockout mice 
Our initial investigations were targeted at the regulation of IL-12p70 in spleen cells 
from p47
phox knockout and wild type (WT) C57BL/6 mice. Spleen cells were 
isolated and stimulated for 20 hrs with LPS and CpG2216. We found in p47
phox-/- 
spleen cells an enhanced mRNA expression of IL-12p35 compared to WT mice 
(Fig. 8a). In addition, a difference between TLR4 and TLR9 signaling was 
discernible, because in WT cells CpG2216 stimulation resulted in a lower 
expression of p35 compared to LPS (TLR4) stimulation (Fig. 8a). IL-12p40 mRNA 
expression was neither different significantly between WT and p47
phox-/- nor 
between TLR4 and TLR9 stimulatory conditions (Fig. 8b). 
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Fig. 8: Analysis of p35 and p40 mRNA.  
With Real Time PCR analysis the expression of IL-12p70 subunits p35 and p40 was 
determined. Enhanced mRNA expression of IL-12p70 subunits p35 (a) was established 
after TLR9 stimulation with CpG (2.5 µM) in p47
phox-/- cells in comparison to wild type cells. 
p40 mRNA was not significantly altered (b). Statistical significance is indicated (n=3, 
***P<0.005, **P<0.01). 
 
In parallel to the detection of mRNA regulation we were interested in the IL-12p70 
protein level. With a mouse specific IL-12p70 ELISA we measured the IL-12p70 
protein in the supernatant from LPS and CpG2216 stimulated spleen cells. 
Corresponding to mRNA protein data revealed an enhanced TLR9-induced IL-
12p70 protein secretion in p47
phox-/- cells compared to WT cells (Fig. 9a). We could 
not detect any difference between p47
phox-/- and WT upon TLR4 stimulation with 
LPS (Fig. 9a). To prove the specificity of the agonistic TLR9 ligand CpG2216 with 
respect to the negative feedback regulation we performed additional experiments 
with antagonistic and control TLR9 ligands. Antagonistic CpG2088 and control 
CpG alone did not stimulate IL-12p70. Although as expected increasing 
concentrations of CpG2088 added to CpG2216 resulted in reduced IL-12p70 
secretion, we observed no substantial change in the TLR9-induced negative 
feedback of IL-12p70 in WT cells (Fig. 9b). 
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Fig. 9: IL-12p70 protein secretion in spleen cells upon TLR stimulation.  
Secretion of IL-12p70 protein, measured by specific ELISA, was also increased in 
CpG2216 stimulated p47
phox-/- cells (a). TLR4 stimulation with LPS (1 µg/ml) showed no 
significant differences between p47
phox-/- and wt cells (a). Co-stimulation of CpG2216 and 
CpG2088 resulted in diminished IL-12p70 secretion, but CpG2088 did not influence the 
negative feedback in wt (b). Statistical significance is indicated (n=3, ***P<0.005, 
*P<0.05).  
 
4.2.1.2 Regulation of IL-12p70 in p47
phox mutated mice 
A problem with the p47
phox knockout mouse is that it does not only differ by the 
defective p47
phox gene in comparison with WT C57BL/6 but also with a large and 
unknown linked chromosomal fragment derived from the 129 strain. To exclude 
the possibility of such linked genetic polymorphisms, as well as differences in the 
remaining background of the poorly defined BL/6 strains, we used a genetically 
better controlled strain with a mutation in the p47
phox gene, leading to ROS 
deficiency, on the B10.Q background (Ncf1*/* mice). To confirm our hypothesis we 
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investigated spleen cells of Ncf1*/* and B10.Q WT mice regarding TLR4- and 
TLR9-induced IL-12p70. Indeed we observed a negative feedback regulation in 
TLR9-induced IL-12p70 in WT cells, while in Ncf1*/* cells IL-12p70 was elevated 
(Fig. 10). 
  
 
 
 
 
 
 
 
 
 
Fig. 10: IL-12p70 secretion in Ncf1*/* spleen cells upon TLR stimulation.  
Secretion of IL-12p70 protein, measured by specific ELISA, was increased in CpG2216 
stimulated Ncf1*/* cells compared to wt cells. After TLR4 stimulation with LPS (1 µg/ml) no 
significant difference between Ncf1*/* and wt cells was observed. Statistical significance is 
indicated (n=5, **P<0.01). 
 
4.2.1.3 Regulation of IL-12p70 in p47
phox mutated rats 
In addition to mouse models with a p47
phox defect we were interested in the rats 
with a SNP at position 153 in the p47
phox protein. The most important point is that 
this SNP is located at a phosphorylation position in p47
phox. Threonin at this 
position can be phosphorylated by IRAK4, but not by PKC which is one of the 
common enzymes activating p47
phox. IRAK4 as a kinase in the TLR signaling 
pathway is related to p47
phox which fits in our hypothesis. As described before rats 
with threonin (DA.Ncf1.
E3) are completely protected to RA and EAE whereas rats 
with methionin (DA.Ncf1.
DA) showed fast onsets and severe progressions of both 
diseases. In our experiments spleen cells from both rat strains were stimulated 
with LPS and CpG2216 and IL-12p70 protein was measured in the supernatant. 
Upon LPS stimulation in both rats no IL-12p70 was detectable (Fig. 11), whereas 
stimulation with CpG2216 resulted in an increased IL-12p70 response in the 
DA.Ncf1.
DA rats compared to DA.Ncf1.
E3 (Fig. 11). 4 Results    Richter 
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Fig. 11: IL-12p70 regulation in rat spleen cells upon TLR stimulation.  
Rat spleen cells were stimulated with LPS [1 µg/ml] and CpG2216 [2.5 µM]. LPS did not 
induce IL-12p70 in both rat strains. In contrast stimulation with TLR9 ligand CpG2216 
resulted in the induction of IL-12p70 with a significant enhanced secretion in DA.Ncf1.
DA 
cells compared to DA.Ncf1.
E3. Statistical significance is indicated (n=4, **P<0.01). 
 
 
4.2.2 IL-23 production upon TLR stimulation in primary spleen cells 
Since IL-23 is also produced by dendritic cells and play an important role in 
chronic inflammation we investigated the IL-23 response to TLR4 and TLR9 
ligands in spleen cells of p47
phox-/- and WT mice. We measured mRNA of the IL-23 
subunit p19 with Real time PCR and the whole protein IL-23 in the supernatant. 
Because IL-23 shares with IL-12p70 the subunit p40 which was investigated 
before we focused in this part on the IL-23 subunit p19. With Real-time PCR 
analyses we measured p19 subunit in TLR stimulated and control spleen cells. We 
could not detect any regulation of p19 neither upon TLR4 nor upon TLR9 
stimulation compared to the control (Fig. 12).  
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Fig. 12: Analysis of p19 mRNA expression.  
With Real Time PCR expression of p19 subunit was measured. Molecule number of p19 
mRNA was not significantly altered upon TLR stimulation with LPS [1 µg/ml] or CpG2216 
[2.5 µM] in WT and p47
phox-/- cells. 
 
With mouse specific IL-23 ELISA we measured IL-23 in the supernatant of TLR4 
and TLR9 stimulated spleen cells. We detected neither upon LPS nor upon 
CpG2216 stimulation IL-23 in the concentrated supernatant (Fig. 13). The 
detection limit of this ELISA is 15.6 pg/ml. Because TLR4 stimulation with LPS 
should induce IL-23 production we conclude from our results that IL-23 producing 
dendritic cells are absent in the spleen. 
  
 
 
 
 
 
 
 
 
 
 
 
Fig. 13: IL-23 ELISA of TLR stimulated spleen cells. 
In TLR4 [1 µg/ml LPS] and TLR9 [2.5 µM CpG2216] stimulated spleen cells from WT and 
p47
phox-/- no IL-23 secretion was detectable. One representative experiment out of 4 is 
shown. 4 Results    Richter 
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4.2.3 Regulation of other cytokines in primary spleen cells 
4.2.3.1 Regulation of IFN-α in p47
phox knockout mice 
In order to confirm the differences between TLR4 and LR9 signaling our interest 
focused also in IFN-α as an important factor in anti-viral immune response. For 
this purpose we stimulated spleen cells of p47
phox-/- and WT mice with LPS and 
CpG2216 and measured IFN-α secretion in the supernatant. We found that IFN-α 
was exclusively induced after stimulation with TLR9 ligand CpG2216, but not after 
LPS, in both groups of mice (Fig. 14). Additionally we observed significant higher 
levels of IFN-α secretion in spleen cells of p47
phox-/- mice compared to WT (Fig. 
14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14: IFN-α secretion in TLR stimulated spleen cells. 
In concentrates of supernatants IFN-α was measured by mouse specific ELISA. 
Exclusively TLR9 stimulation with CpG2216 (2.5 µM) resulted in secretion of IFN-α. In 
p47
phox-/- cells IFN-α is significantly increased in comparison to wt cells. Statistical 
significance is indicated (n=4, ***P<0.005). 
 
4.2.3.2 Regulation of IL-10 in p47
phox knockout and mutated mice 
To follow up our hypothesis regarding p47
phox regulation in TLR signaling we 
extended our investigations towards additional immune regulatory cytokines. To 
this end we stimulated spleen cells of p47
phox-/- and WT mice with LPS and 
CpG2216 and measured IL-10 secretion after a 20 hrs incubation period. IL-10 
protein levels were significantly elevated in p47
phox-/- cells after TLR9 stimulation 
compared to WT conditions (Fig. 15a). In contrast, a TLR4 mediated response 4 Results    Richter 
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through stimulation with LPS led to IL-10 secretion with no difference between 
p47
phox-/- and WT cells (Fig. 15a). In parallel we measured also IL-10 secretion in 
Ncf1
*/* mice and detected significantly lower levels after TLR9 stimulation in WT 
compared to p47
phox mutants (Fig. 15b). In contrast to the experiments with the 
p47
phox knockout mice we also measured decreased IL-10 secretion in WT cells 
upon TLR4 stimulation with LPS (Fig. 15b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15: IL-10 secretion of TLR stimulated spleen cells.  
IL-10 secretion in TLR9-stimulated p47
phox-/- cells was significantly increased compared to 
wt cells (a). Upon TLR4 stimulation there is no significant difference in IL-10 secretion 
detectable (a). In Ncf1
*/* spleen cells IL-10 is increased upon TLR9 and TLR4 stimulation 
compared to the WT cells. Statistical significance is indicated (n=4, ***P<0.005, *P<0.05). 
 
4.2.4 ROS independent feedback regulation of IL-12p70 
4.2.4.1 Comparison of p47
phox and gp91
phox knockout spleen cells 
To investigate whether the observed unrestrained TLR9 mediated IL-12p70 
response in cells lacking p47
phox is independent of the lack of ROS production we 
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performed control experiments with spleen cells from gp91
phox-/- mice. Like p47
phox-
/- cells functionally these are also unable to assemble an active NADPH oxidase. 
Stimulation of spleen cells from gp91
phox-/- mice with the TLR9 ligand resulted in a 
decreased IL-12p70 secretion as shown in WT cells before, whereas again 
p47
phox-/- mice secrete significantly more IL-12p70 after CpG2216 stimulation (Fig. 
16). 
 
 
 
 
 
 
 
 
 
Fig. 16: Comparison of p47
phox-/- and gp91
phox-/- spleen cells regarding IL-12p70. 
IL-12p70 was measured in the supernatants of spleen cells upon incubation with LPS [1 
µg/ml] and CpG ODN2216 [2.5 µM] for 20 hrs. In both, WT and gp91
phox-/- spleen cells 
TLR9-induced IL-12p70 secretion was comparable. In contrast IL-12p70 in p47
phox-/- cells 
was significantly increased after TLR9 stimulation. Statistical significance is indicated 
(n=3, *P<0.05, **P<0.01). 
 
4.2.4.2 Inhibition of ROS with DPI 
Further experiments to confirm a ROS-independent role of p47
phox were performed 
with an inhibitor of ROS production, DPI. Spleen cells were investigated regarding 
their inducible ROS production by pre-stimulation with LPS or CpG2216. 
Additional samples were stimulated with PMA to induce ROS production and 
measured at different time points. In the process we detected higher levels of ROS 
in WT cells pre-treated with LPS and CpG2216, whereas as expected ROS 
production in p47
phox-/- cells was not detectable (Fig. 17a). Parallel to ROS 
measurement IL-12p70 secretion was determined in p47
phox-/- and WT cells. 
Although ROS formation was undetectable after DPI treatment (Fig. 17b) no 
impact on feedback regulation by p47
phox-/- in TLR9 signaling was observed (Fig. 4 Results    Richter 
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17c). Surprisingly, after blockade of ROS production the feedback regulation is 
now clearly observable also in TLR4 signaling (Fig. 17d).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17: Measurement of ROS and ROS-independent regulation of IL-12p70. 
Measurement of ROS production via Amplex Red detects after PMA treatment [100 nM] 
increased ROS only in WT cells pre-stimulated with LPS [1 µg/ml] or CpG2216 [2.5 µM], 
whereas ROS production in p47
phox-/- cells was absent (a). After inhibition of NADPH 
oxidase by DPI [5 µM] ROS production was completely abolished (b). The grey line 
marked the basal production of ROS. One representative experiment out of four is shown. 
IL-12p70 secretion was measured in the supernatants of spleen cells after incubation with 
LPS [1 µg/ml] and CpG2216 [2.5 µM] or in combination with DPI [5 µM] after 20 hrs. 
Secretion of IL-12p70 protein was increased in p47
phox-/- cells after TLR9 stimulation alone 
as well as in combination with Inhibitor DPI compared to wt cells (c). DPI treatment 
resulted also in decreased levels of IL-12p70 in TLR4 stimulated wt cells. This effect was 
not observable in wt cells treated with LPS [1 µg/ml] alone (D). Statistical significance is 
indicated (n=3, *P<0.05, **P<0.01). 
 
4.2.5 MyD88 dependent regulation of IL-12p70 
In order to evaluate the relative contribution of different TLR downstream signaling 
adaptor modules we performed further experiments with MyD88
-/- and TRIF
-/- mice. 
In MyD88
-/- and TRIF
-/- spleen cells, stimulated with the TLR4 ligand LPS, IL-
12p70 secretion was markedly reduced due to lack of either the MyD88- or TRIF-
dependent signaling pathway. When cells were stimulated with TLR9 agonist 
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CpG2216 IL-12p70 secretion was completely abolished in both MyD88
-/- and TRIF
-
/- cells (Fig. 18).  
 
 
 
 
 
 
 
 
Fig. 18: IL-12p70 secretion in spleen cells of MyD88
-/- and TRIF
-/- mice. 
After LPS stimulation decreased IL-12p70 was observed in both, MyD88
-/- and TRIF
-/- 
compared to wt and p47
phox-/- cells. After TLR9 stimulation with CpG2216 exclusively in 
p47
phox-/- cells IL-12p70 was detected. One representative experiment out of two is shown. 
 
4.2.6 IL-12p70 regulation in CD11c
+ enriched spleen cells 
Since all experiments so far had been performed in whole spleen cells we 
reasoned which specific cell type might be responsible for the negative feedback 
regulation of IL-12p70. In the spleen, dendritic cells are one of the major IL-12p70 
producers. To investigate the role of dendritic cells we isolated CD11c positive 
cells from the spleen as described before and stimulated CD11c
+ and CD11c
- cells 
with TLR4 and TLR9 ligands. IL-12p70 was enhanced after TLR4 stimulation in 
both, p47
phox-/- and wild type CD11c
+ cells (Fig. 19a). Stimulation with TLR9 ligand 
CpG2216 only resulted in elevated IL-12p70 secretion in p47
phox-/- CD11c
+ cells 
compared to wild type CD11c
+ cells (Fig. 19a). In comparison to CD11c
+ spleen 
cells CD11c
- cells clearly showed a lower IL-12p70 secretion after TLR4 
stimulation and hardly detectable IL-12p70 after TLR9 stimulation (Fig. 19b). 
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Fig. 19: IL-12p70 secretion of CD11c
+ dendritic cells. 
Purified CD11c
+ spleen cells from p47
phox-/- mice stimulated with CpG2216 [2.5 µM] 
exhibited an increased IL-12p70 secretion compared to WT cells (a). Upon TLR4 
stimulation with LPS [1 µg/ml] showed no significant difference between WT and p47
phox-/- 
cells (a). In contrast CD11c
- cells secreted no IL-12p70 upon TLR9 stimulation with 
CpG2216 and hardly IL-12p70 upon LPS stimulation (b). Statistical significance is 
indicated (n=3, *P<0.05, **P<0.01). 
 
 
In parallel as a control we monitored the isolation and purification of spleen cells 
by FACS. Therefore cells from all three fractions; original, CD11c
+ and CD11c
- 
were incubated with CD11c FACS antibodies for 15 min. Finally cells were 
measured and counted by FACS. Results show that we were able to enrich 
CD11c
+ cells from 3.5% in whole spleen cell suspension to about 78% of CD11c
+ 
positive cells (Fig. 20). 
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Fig. 20: FACS analysis of CD11c purified spleen cells. 
Original, CD11c
+ and CD11c
- spleen cells were measured by FACS. From 3.5% CD11c
+ 
cells in the original spleen cell fraction 78.1% CD11c
+ cells were enriched. Data are 
representative for 3 different experiments. 
 
 
4.2.7 IL-12p70 and IL-23 regulation in BM-derived DCs 
4.2.7.1 IL-12p70 and IL-23 regulation in BM-derived mDCs 
Because in the spleen we determined only DCs producing IL-12p70 we decided to 
investigate other DC sources such as the BM. The advantage over the purification 
of splenic DCs is that from BM precursor cells much higher numbers of specific 
DCs can be differentiated with certain protocols. We used two different protocols 
to obtain mDCs and pDCs, respectively (described in 3.2.5). In the following 
experiments we used cells from WT C57BL/6 and p47
phox-/- mice.  
Upon stimulation of differentiated mDCs with TLR4 (1 µg/ml LPS) and TLR9 (2.5 
µM CpG2216) ligands we detected IL-12p70 secretion. Whereas upon LPS 
stimulation in p47
phox-/- cells IL-12p70 was comparable to WT cells upon TLR9 
stimulation IL-12p70 was enhanced in p47
phox-/- (Fig. 21a). Additionally to IL-12p70 
we investigated also the IL-23 response of those cells and observed in contrast to 
the variations of the IL-12p70 secretion upon TLR9 stimulation no significant 
difference of IL-23 between WT and p47
phox-/- under the same conditions (Fig. 
21b).  
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Fig. 21: IL-12p70 and IL-23 regulation in BM-derived mDCs. 
IL-12p70 secretion was increased in TLR9 stimulated mDCs from p47
phox-/- mice 
compared to WT (a). Upon LPS stimulation no difference was observed (a). In contrast to 
IL-12p70 secretion we detected no difference of IL-23 between p47
phox-/- and WT cells 
upon TLR4 and TLR9 stimulation (b). Statistical significance is indicated (n=4, *P<0.05). 
 
4.2.7.3 IL-12p70 and IL-23 regulation in BM-derived pDCs 
We showed that BM-derived differentiated mDCs produce both cytokines, IL-
12p70 and IL-23. Furthermore we observed differences in TLR9 stimulated IL-
12p70 secretion between WT and p47
phox-/- mDCs. In parallel to the mDCs we 
were also interested in the secretion of both cytokines by pDCs. We stimulated 
BM-derived pDCs from WT and p47
phox-/- mice with TLR4 and TLR9 ligands and 
measured IL-12p70 and IL-23. Upon TLR4 stimulation pDCs produced no 
detectable amounts of IL-12p70, whereas upon TLR9 stimulation IL-12p70 was 
increased in both, p47
phox-/- a n d  W T  c e l l s  ( Fig. 22a). On the other hand IL-23 
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secretion was completely absent in TLR4 stimulated pDCs and hardly detectable 
upon TLR9 stimulation in p47
phox-/- and WT cells (Fig. 22b). 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 22: IL-12p70 and IL-23 regulation in bone-marrow derived pDCs. 
IL-12p70 secretion was increased in TLR9 stimulated pDCs from both, p47
phox-/- and WT 
cells (a). Upon LPS stimulation no IL-12p70 was detectable (a). In contrast to IL-12p70 
secretion we measured less IL-23 upon TLR9 stimulation in p47
phox-/- and WT cells, but no 
IL-23 upon TLR4 (b). One representative experiment out of 3 is shown.  
 
4.2.7.3 Characterization of BM-derived mDC and pDC by CD antigens 
BM-derived cells, differentiated with GM-CSF or Flt3-L, can be characterized by 
specific CD antigens. Although there are different CD antigens for the 
characterization of DCs in this experiment only two typical marker, CD11c and 
B220, were applied. GM-CSF differentiated BM cells contained two main 
populations. First, one fraction is CD11c
+ and B220
- (48.76%), which is the typical 
DC fraction (Fig.23a). The other fraction is negative for both markers (49.5%, 
Fig.23a). In contrast Flt3-L differentiated cells are divided into three main 
populations. First there is a CD11c
+ and B220
-  population (25.57%), second a 
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CD11c
+ and B220
+ fraction (13.78%) and third a population which is negative for 
both markers (48.25%, Fig.23b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 23: FACS analysis of BM cells differentiated with GM-CSF or Flt3-L 
GM-CSF differentiated cells include a fraction of cells positive for CD11c and negative for 
B220 (48.76%). In contrast Flt3-L differentiation results in two different populations, a 
CD11c
+ and B220
- fraction (25.57%) but additionally a population which is CD11c
+ and 
B220
+ (13.78%). With both differentiation protocols a population completely negative for 
CD11c and B220 (approx. 50%) arises. One representative analysis out of 3 is displayed. 
 
4.2.8 Adjuvant-guided T cell response in vivo 
4.2.8.1 Th1 response of OVA re-stimulated LN cells and spleen cells 
Reasoning that the induction of the 3
rd signal, i.e. IL-12p70 elicited by the TLR9 
ligand CpG2216 in dendritic cells, should strongly enhance a Th1-polarized 
antigen-specific response in p47
phox-/- mice in vivo, too, we performed 
immunization experiments closely resembling the classical DTH-like protocols. 
Mice received either PBS, OVA alone or mixed with CpG2216 in IFA s.c. to 
activate and polarize naïve T-cells towards IFN-γ producing Th1 cells. After ten 
days isolated LN cells from immunized p47
phox-/- and WT mice were incubated in 
an ELISA spot assay with or without OVA and the frequency of IFN-γ producing T 
cells was quantified. LN cells from both mouse strains treated with PBS in vivo 
exhibited no IFN-γ production upon re-stimulation with OVA (Fig. 24a). In vitro 
recall of OVA immunization of WT and p47
phox-/- mice resulted in an increased IFN-
γ frequency in the p47
phox-/- LN cells (Fig. 24b). Providing a polarization signal, in 
our case IL-12p70 induced by TLR9 activation with CpG2216, enhanced the 
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frequency of IFN-γ-producing Th1 in WT mice significantly (Fig. 24c). However, in 
p47
phox-/- LN cells the IFN-γ response, being already detectable without in vitro 
OVA re-stimulation, was strongly augmented upon OVA re-stimulation (Fig. 24c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 24: Th1 response of lymph node cells from immunized mice. 
Lymph node cells from in vivo immunized mice were in vitro stimulated with OVA and IFN-
γ frequency was measured by ELISPOT. LN cells from control groups (PBS) produced no 
IFN-γ upon re-stimulation with OVA (a). OVA immunization resulted in IFN-γ response 
upon OVA re-stimulation only in p47
phox-/- LN cells (b). Combined injection of OVA and 
CpG2216 increased the IFN-γ response in both, p47
phox-/- and WT cells upon re-stimulation 
with OVA (c). Additionally p47
phox-/- cells already produce IFN-γ without OVA re-stimulation 
which is further enhanced upon OVA treatment (c). Statistical significance is indicated 
(n=5, *P<0.05, **P<0.01).  
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In parallel to LN cells we investigated also spleen cells from immunized mice 
regarding their Th1 response. Therefore freshly isolated spleen cells were seeded 
in ELISPOT plates, re-stimulated with OVA or left untreated and IFN-γ frequency 
was measured. In comparison to the LN cells we detected no significant increase 
of IFN-γ in spleen cells from control and OVA immunized mice (Fig. 25a, b). 
Combined treatment of OVA and CpG2216 resulted in enhanced IFN-γ response 
in p47
phox-/- and WT cells upon OVA re-stimulation with a higher extent in p47
phox-/- 
spleen cells (Fig. 25c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 25: Th1 response of spleen cells from immunized mice.  
IFN-γ frequency of control, OVA and OVA/CpG immunized mice was detected by 
ELISPOT. Spleen cells of control and OVA immunized mice showed no enhanced IFN-γ 
response upon OVA re-stimulation (a, b). Both, p47
phox-/- and WT spleen cells treated with 
OVA and CpG exhibited increased IFN-γ frequency upon OVA stimulation in vitro (c). 
Furthermore spleen cells from p47
phox-/- mice, immunized with OVA and CpG produced 
higher amounts of IFN-γ upon OVA re-stimulation compared to WT cells (c). Statistical 
significance is indicated (n=5, *P<0.05, ***P<0.001) 
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4.2.8.2 IL-12p70 response in LN cells from immunized mice in vitro 
Because the polarization of naïve T cells into T helper cells requires a 3
rd signal 
produced by antigen presenting cells like dendritic cells. For the Th1 polarization 
thie main signal is IL-12p70 which is secreted by dendritic cells upon uptake of 
antigens and simultaneous stimulation of pathogen recognition receptors, i.e. 
TLRs. To investigate whether the Th1 response is induced by IL-12p70 we 
stimulated LN cells from immunized p47
phox-/- and WT mice with TLR4 ligand LPS 
(1 µg/ml) and TLR9 ligand CpG2216 (2.5 µM) in vitro and determined the IL-12p70 
response by mouse specific ELISA. LN cells of control WT mice exhibited low 
amounts of IL-12p70 in response to LPS and CpG2216, whereas in p47
phox-/- LN 
cells IL-12p70 was increased upon CpG2216 stimulation (Fig. 26a). Mice 
immunized with OVA showed roughly the same response as the PBS treated mice 
(Fig. 26b). In contrast to WT mice LN cells from p47
phox-/- mice treated with OVA 
and CpG2216 in vivo are characterized by an enhanced IL-12p70 response upon 
TLR4 and TLR9 stimulation (Fig. 26c). 
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Fig. 26: IL-12p70 response of LN cells measured by mouse specific ELISA. 
LN cells from control mice (PBS treated) stimulated with TLR4 ligand LPS showed no IL-
12p70 response (a). TLR9 stimulation with CpG2216 resulted only in p47
phox-/- control cells 
in enhanced IL-12p70 (a). OVA immunized LN cells exhibited only low amounts of IL-
12p70 upon TLR4 and TLR9 stimulation with a slight increase in p47
phox-/- cells upon TLR9 
stimulation (b). Immunization with OVA combined with CpG2216 resulted only in p47
phox-/- 
LN cells to an upregulation of IL-12p70 upon TLR4 and TLR9 stimulation, respectively (c). 
One representative experiment out of 2 is shown.  
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4.2.8.3 Th17 response of OVA re-stimulated LN cells and spleen cells 
In chronic inflammation not only Th1 response but also Th17 cells play an 
important role. Th17 cells are characterized by the production of IL-17. In contrast 
to the Th1 development that involves IL-12p70 Th17 cells were stabilized and 
survived by the availability of IL-23. In our experiments p47
phox-/- and WT mice 
were immunized with OVA, a combination of OVA and CpG2216 or with PBS as 
control for 10 days. Subsequently LN and spleen cells were isolated, seeded into 
ELISPOT plates and directly re-stimulated with OVA or left untreated. After 24 hrs 
incubation time, plates were washed, specific IL-17 detection antibodies were 
used and finally IL-17 production was detected as spots on the plates. In control 
mice no IL-17 response has been detected in LN cells re-stimulated with OVA in 
vitro (Fig. 27a). LN cells from OVA immunized mice exhibited also no detectable 
IL-17 response except LN cells from p47
phox-/- upon re-stimulation with OVA (Fig. 
27b). In contrast immunization of mice with OVA in combination with CpG2216 
resulted in increased Th17 response upon OVA re-stimulation with a higher extent 
in p47
phox-/- cells (Fig. 27c). Additionally OVA and CpG2216 immunized p47
phox-/- 
mice already showed enhanced IL-17 spots in in vitro untreated LN cells (Fig. 
27c). 
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Fig. 27: Th17 response of LN cells from immunized mice. 
IL-17 response was measured with ELISPOT using specific IL-17 antibodies. LN cells 
from control mice exhibited no IL-17 response (c). In OVA immunized group only LN cells 
from p47
phox-/- mice showed increased IL-17 spots upon OVA re-stimulation in vitro (b). In 
contrast both, p47
phox-/- and WT cells from OVA and CpG2216 immunized mice produce 
IL-17 upon re-stimulation with OVA, whereas p47
phox-/- cells already secrete IL-17 without 
OVA re-stimulation in vitro (c). Statistical significance is indicated (n=5, *P<0.05, 
**P<0.01) 
 
 
In addition to the LN cells from immunized mice we further determined the Th17 
response of spleen cells from those mice. Therefore freshly isolated spleen cells 
were in an IL-17 specific ELISPOT investigated. As described before spleen cells 
were in vitro re-stimulated with OVA or left untreated. We measured in spleen cells 
from the control group low amounts of IL-17 with a slight increase in p47
phox-/- 
treated with OVA in vitro (Fig. 28a). Mice immunized with OVA alone showed an 
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enhanced Th17 response upon OVA re-stimulation, whereas p47
phox-/- mice 
exhibited a clear increase of IL-17 of both, untreated and OVA re-stimulated cells 
(Fig. 28b). When mice were immunized with a combination of OVA and CpG2216 
IL-17 response in spleen cells of both, p47
phox-/- and WT was significantly 
increased upon re-stimulation with OVA with a higher extent in p47
phox-/- cells (Fig. 
28c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28: Th17 response of spleen cells from immunized mice. 
With IL-17 ELISPOT Th17 response of spleen cells from immunized mice was detected. 
Spleen cells of control mice exhibited a slight increase of IL-17 when treated with OVA in 
vitro, but only significantly in p47
phox-/- cells (a). Immunization with OVA resulted in 
enhanced IL-17 response upon OVA re-stimulation in both mice, whereas IL-17 spots of 
p47
phox-/- cells are already enhanced without OVA (b). Spleen cells from mice treated with 
OVA and CpG2216 showed increased IL-17 response upon re-stimulation with OVA in 
vitro (c). Statistical significance is indicated (n=5, *P<0.05, **P<0.01, ***P<0.001) 
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4.2.8.4 IL-23 response LN cells from immunized mice in vitro 
Based on the fact that IL-23 plays an important role for the development and 
survival of Th17 cells we wanted to know whether IL-23 secretion is influenced by 
p47
phox as shown before for IL-12p70. In this context we stimulated LN cells from 
immunized p47
phox-/- and WT mice with TLR4 and TLR9 ligands. Therefore LN 
cells were thawed and seeded 10-15x10
6/ml in T25 culture flasks. Cells were 
incubated for 6-8 hrs in medium containing FCS. Afterwards LN cells were 
stimulated in serum-free medium with LPS and CpG2216, respectively and after 
20 hrs IL-23 was measured in the supernatant by ELISA. We neither detected in 
p47
phox-/- nor WT cells any secretion of IL-23 after TLR stimulation (Fig. 29a-c). In 
this respect it was irrelevant whether LN cells were derived from control or 
immunized mice (Fig. 29a-c).   
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Fig. 29: IL-23 response of LN cells measured by mouse specific ELISA. 
LN cells from control and immunized p47
phox-/- and WT cells were stimulated with LPS and 
CpG2216, respectively. There was no IL-23 secretion detectable in LN cells from p47
phox-/- 
and WT mice of all three groups (a-c). 
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4.3 Role of Vitamin D3 on IL-12p70 expression 
It is known that VD3 has immunomodulatory functions. Since it was shown that 
VD3 stimulates the phagocytosis and the bacterial killing capacity but suppresses 
the antigen-presentation in the following experiments the influence of VD3 
treatment on IL-12p70 secretion by DCs has to be investigated. The enhanced 
phagocytic activity upon VD3 treatment was shown to be mediated via an 
upregulation of p47
phox. Based on the previous results that IL-12p70 is increased 
when p47
phox is absent in the following experiments also the association between 
VD3 and p47
phox should be noticed. 
 
4.3.1 IL-12p70 regulation by VD3 in different mouse strains 
4.3.1.1 IL-12p70 regulation in C57BL/6 spleen cells 
In an initial experiment we wanted to know whether short term treatment with VD3 
influences the ability of spleen DCs to secrete IL-12p70 upon stimulation with TLR 
ligands. Freshly isolated spleen cells were cultivated in medium containing VD3 
(10
-7M) before TLR stimulation (0-24 hrs), before and during TLR stimulation (0-48 
hrs), only during TLR stimulation (24-48 hrs) or left untreated (w/o). Cells were 
stimulated with LPS (1 µg/ml) or CpG2216 (2.5 µM) for 24 hrs and IL-12p70 was 
measured in the supernatant. LPS induced IL-12p70 in untreated cells. VD3 
treatment inhibited LPS-induced IL-12p70 when cells were treated before 
stimulation (Fig. 30a, 0-24 hrs). Spleen cells incubated with VD3 before and during 
stimulation exhibited comparable inhibition of IL-12p70 (Fig. 30a, 0-48 hrs), 
whereas treatment with VD3 only during LPS stimulation had no influence (Fig. 
30a, 24-48 hrs). In contrast to high secretion upon LPS spleen cells stimulated 
with CpG2216 produced low levels of IL-12p70, as observed in spleen cell 
experiments before. However, VD3 treatment before stimulation (0-24 hrs) as well 
as over the whole period (0-48 hrs) resulted in decreased IL-12p70 (Fig. 30b). 
Incubation with VD3 during CpG2216 stimulation did not significantly inhibit IL-
12p70 (Fig. 30b, 24-48 hrs). 
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Fig. 30: IL-12p70 regulation by VD3 in C57BL/6 spleen cells. 
VD3 treatment before stimulation with LPS [1 µg/ml] or during the whole period resulted in 
decreased IL-12p70 (a, 0-24 hrs, 0-48 hrs). In contrast treatment with VD3 only during 
stimulation had no effect on IL-12p70 secretion (a, 24-48 hrs). Although upon CpG2216 
[2.5 µM] stimulation IL-12p70 response was much lower than upon LPS the IL-12p70 
pattern upon VD3 treatment was comparable (b). Statistical significance is indicated (n=5, 
*P<0.05, **P<0.01, ***P<0.001) 
 
 
4.3.1.2 IL-12p70 regulation in BALB/c spleen cells 
From the experiments with C57BL/6 mice we know that IL-12p70 is regulated by 
VD3. Since it was shown that TNBS-induced colitis in BALB/c mice was improved 
by in vivo VD3 application (Daniel, 2008) we wanted to clarify whether spleen cells 
from those mice also have an altered IL-12p70 response due to a VD3 treatment in 
vitro. Therefore spleen cells from 10-12 weeks old BALB/c mice were isolated and 
cultivated in medium containing VD3 (10
-7 M) before TLR stimulation (0-24 hrs), 
before and during TLR stimulation (0-48 hrs), only during TLR stimulation (24-48 
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hrs) or left untreated (w/o). TLR stimulation with LPS and CpG2216 was 
performed as described above. In comparison to the C57BL/6 mice spleen cells 
from BALB/c mice exhibited almost the same IL-12p70 pattern. VD3 treatment 
resulted in decreased IL-12p70 response when applied before TLR stimulation 
with LPS (Fig. 31a) or CpG2216 (Fig. 31b). In contrast to the C57BL/6 experiment 
VD3 influences the IL-12p70 response in BALB/c cells upon LPS stimulation also 
when applied only during TLR stimulation (Fig. 31a, black bar). Upon TLR9 
stimulation with CpG2216 this significant altered IL-12p70 response was not 
observable (Fig. 31b, black bar). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 31: IL-12p70 regulation by VD3 in BALB/c spleen cells. 
IL-12p70 response upon LPS or CpG2216 stimulation was decreased by VD3 treatment 
before (0-24 hrs) or before and during (0-48 hrs) TLR stimulation (a, b, gray bars). 
Cultivation of spleen cells exclusively during TLR stimulation resulted only upon LPS 
stimulation in significantly decreased IL-12p70 response (a, black bar). Statistical 
significance is indicated (n=5, **P<0.01, ***P<0.001) 
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4.3.2 IL-12p70 regulation by VD3 in CD11c
+ cells 
In summary so far we figured out that VD3 regulates the IL-12p70 response in 
spleen cells from C57BL/6 and BALB/c mice. To confirm that these effects arise 
from the DCs in the spleen we additionally purified CD11c positive DCs. We 
performed an experiment where we cultured CD11c
+ cells in medium containing 
VD3 (10
-7 M) or left untreated and stimulated those cells again with TLR4 and 
TLR9 ligands. As expected from the previous experiments we detected a 
decreased IL-12p70 secretion from cells treated before (0-24 hrs) and 
before/during (0-48 hrs) TLR stimulation, respectively (Fig. 32a, b).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 32: Regulation of VD3 in CD11c
+ spleen cells. 
IL-12p70 secretion was diminished in CD11c
+ cells treated with VD3 before and 
before/during TLR4 and TLR9 stimulation (a, b, gray bars). This experiment only was 
performed 2 times. 
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4.3.3 IL-12p70 regulation by VD3 in p47
phox-/- and WT spleen cells 
Since it was described that VD3 influences the mRNA expression of p47
phox 
(Fuhrman, 2004) we wanted to know whether those finding could be confirmed in 
our cells regarding the impact on the IL-12p70 response. Therefore spleen cells 
from p47
phox-/- and WT mice were isolated and directly treated with VD3 or left 
untreated. After 24 hrs cells were stimulated with TLR4 ligand LPS and TLR9 
ligand CpG2216. In comparison to the untreated cells (100%) VD3 treatment 
before stimulation resulted in reduced IL-12p70 upon TLR4 stimulation in WT and 
p47
phox-/- cells by 45-55% (Fig. 33a). In contrast to LPS stimulation VD3 treatment 
diminished TLR9 induced IL-12p70 only by 20% in p47
phox-/- cells whereas in WT 
cells IL-12p70 was again reduced by 40% (Fig. 33b)     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 33: Percentage of IL-12p70 reduction by VD3 in p47
phox-/- and WT cells. 
TLR4 induced IL-12p70 secretion was reduced by 45-55% upon VD3 treatment in WT and 
p47
phox-/- spleen cells (a). VD3 treated WT cells stimulated with TLR9 ligand demonstrated 
also 40% reduction of IL-12p70, whereas only 20% reduction was observed in p47
phox-/- 
cells. One of 2 independent experiments is shown. 
 
With the previous investigations it was demonstrated that short term treatment with 
VD3 resulted in diminished IL-12p70 production of DCs. Whether p47
phox is 
associated with this VD3 effect on the IL-12p70 expression has to be determined in 
more detail. 
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5 Discussion 
DCs as the major producer of IL-23 and/or IL-12p70 play an important role in the 
regulation of immune responses. They do not only induce the T cell response by 
presenting antigens, they also determine the polarization of T cells by supporting 
the 3
rd signal - their specific cytokines, such as IL-12p70 or IL-23. This thesis 
focused on the regulation of TLR-mediated cytokine secretion of different DC 
populations. Because these two cytokines are associated with several immune 
disorders, such as autoimmunity or cancer, our investigations of three different 
molecules, regulating these cytokines, may be demonstrate some new and 
promising approaches. Although these three molecules have distinct functions, 
they are all associated with autoimmune disorders and, demonstrated in this 
thesis, represent regulatory potential on the TLR-mediated cytokine secretion of 
DCs. 
5.1 Regulation of IL-23 by Selenium  
Investigating the role of Selenium on the expression and secretion of IL-23 the 
main focus was on DCs from the skin, the cell line XS-52 as a model for iLCs. It 
has been reported that Selenium deficiency correlates with decreased T cell 
numbers in HIV patients and enhanced susceptibility to skin tumor formation in 
human and mice (Clark, 1984). Supplementation with inorganic Selenium which 
rapidly incorporates into selenoproteins increases the number of skin Langerhans 
cells and thus protects mice from skin tumor formation upon UVB irradiation 
(Rafferty, 2003). The findings of the experiments in this thesis clearly 
demonstrated a stimulatory effect of Selenium on the IL-23 secretion by iLCs. In 
the experiments concentrations between 10 and 250 nM exhibited enhanced IL-23 
production. It has been shown that Ebselen in relatively high concentrations (10-20 
µM) inhibits the IL-12p40 production of iLC (Matsue, 2003). These findings are the 
opposite to the results of this thesis whereas the Selenium concentration was 
much lower than in the cited publication. 
In colon cancer cells treatment with Selenium resulted in an enhanced oxidative 
stress response and increasing ROS levels (Huang, 2009). The induction of free 
radicals by Selenium treatment is further associated with the induction of 
apoptosis (Nilsonne, 2006) which should explain the anti-tumor effects of 5 Discussion    Richter 
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Selenium. From the obtained data it is clear that LPS induces IL-23 and this is 
further enhanced by Selenium. Whether the increased ROS production influences 
the LPS-induced IL-23 secretion was not determined. Thus, for the better 
understanding of the results it will be necessary to investigate this point more 
detail. As demonstrated for mRNA and protein level IL-23 subunit p19 is 
completely unaffected by Selenium treatment whereas p40 is upregulated. In the 
literature there is no evidence that IL-23 or specifically its subunit p40 is 
upregulated by Selenium. As discussed above the opposite function of Selenium 
was demonstrated. To strengthen the findings of this study further investigation 
regarding ROS induction and activation of selenoproteins such as Trx reductase 
should be performed. 
 
5.2 Regulation of IL-12p70 and IL-23 by p47
phox 
In this part of the thesis the hypothesis has been addressed that p47
phox, 
independently of its role for NADPH oxidase activation, is involved in the 
regulation of TLR signaling. Maintaining the balance of the immune response is 
essential to avoid autoimmune reactions or chronic inflammatory processes. Since 
it was shown that the absence of p47
phox is associated with enhanced 
autoimmunity (Olofsson, 2003; Hultqvist, 2004) the question had to be answered 
whether p47
phox directly interact with the TLR signaling to influence the IL-12p70 
and IL-23 production of DCs. In the first set of experiments spleen cells of p47
phox 
deficient mice exhibited an increased IL-12p70 secretion after stimulation of the 
intracellular TLR9 with CpG2216 compared to WT cells. Consequently the 
reduced secretion of IL-12p70 observed after TLR9 stimulation in WT cells seems 
to be controlled by a negative feedback mechanism. This observation may 
important to prevent excessive proinflammatory immune responses against foreign 
molecular structures derived from invading pathogens. That TLR4 induced IL-
12p70 secretion was not different between p47
phox-/- and WT cells is explainable, 
because TLR4 signaling pathways are mediated via two different adaptor 
molecules. First via the adaptor MyD88, this is equally to the TLR9 signaling and 
second via TRIF, which is not involved in the TLR9 pathway. It has been found 
that type A CpGs, including the applied CpG2216, do not induce IL-12p70 in 
human PBMCs (Ghosh, 2007), whereas type B CpGs can also activate B cells in 5 Discussion    Richter 
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humans and induce the secretion of IL-12p70 in GM-CSF-differentiated BM cells 
derived from C57BL/6 mice (Theiner, 2008). Furthermore it has been described for 
pDCs that type A CpGs are weak inducers of TLR9-dependent NF-κB signaling, 
resulting in IL-12p70 expression, but strong inducers of IFN-α (Rothenfusser, 
2002; Verthelyi, 2003; Krieg, 2007). Thus, in this study it should be demonstrated, 
that p47
phox beeing involved in the down-regulation of TLR9-mediated IL-12p70 
secretion in WT cells, is the main factor for this effect. In addition to the genetically 
engineered p47
phox deficient mice a strain with a spontaneous mutation in the 
p47
phox gene Ncf1, resulting in less or no functional splice variants of p47
phox 
protein, have been investigated. In these mice it has been shown earlier that Ncf1 
polymorphism is associated with RA and that the deficiency of p47
phox led to more 
severe inflammation (Hultqvist, 2004). With regard to the regulation of IL-12p70 it 
has been demonstrated that also in this natural mutated mice the lack of p47
phox 
results in increased IL-12p70 production by splenocytes. Because little is known 
about the mechanism how p47
phox could influence the IL-12p70 expression by 
interaction with the TLR signaling pathway in a further experiment rats with a SNP 
in the p47
phox were investigated regarding the IL-12p70 secretion. Although in the 
rats just one single amino acid is different compared to the normal p47
phox protein, 
the IL-12p70 secretion of splenocytes was significantly increased compared to WT 
rats. In disease models those rats were shown to be susceptible to RA and EAE 
when a SNP at amino acid position 153 resulted in methionine instead of threonine 
(Olofsson, 2003). Interestingly this amino acid position is one of the most 
important phosphorylation sites for the IRAK4, one of the key kinases in the TLR 
pathway (Pacquelet, 2007). Possibly with these findings and the fact that IRAK4 
phosphorylates p47
phox a further piece of evidence is collected to uncover a 
connection between p47
phox and the TLR signaling cascade.  
To test whether only proinflammatory IL-12p70 is affected by p47
phox activity also 
two other important cytokines were investigated. In addition to the antiviral 
response IFN-α the expression of the more regulatory IL-10 after stimulation with 
LPS and CpG2216 was determined. Thereby significantly lower IFN-α and IL-10 
levels upon TLR9 stimulation were detected in WT cells whereas in p47
phox-/- 
splenocytes both cytokines are upregulated. After TLR4 stimulation no difference 
between WT and p47
phox deficient cells was discernible for IL-10 and furthermore 
IFN-α response was not detected. The mechanism of IL-10 regulation via different 5 Discussion    Richter 
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TLR pathways and the role of p47
phox is unclear, and published data regarding a 
connection between IL-10 and IL-12p70 regulation and the respective cellular 
sources of either cytokine are manifold and partly contradictory (Flores, 2007; 
Boonstra, 2006; Bohnenkamp, 2007). Because the spleen cell system consists of 
a variety of immune cells, the cells producing IL-12p70 may differ from the IL-10 
producing cells. The high amounts of secreted IFN-α determined in splenocytes 
from p47
phox-/- cells and moderate levels in WT cells points to an involvement of 
IFN-producing DCs such as pDCs. Thus, pDCs, which are the major producers of 
IFN-α, may be specifically sensitive to p47
phox feedback. In addition, the type of 
CpG being agonistic and resulting in a strong IFN-α response support a pDC 
involvement (Asselin-Paturel and Trinchieri, 2005; Krieg, 2002). To prove whether 
pDCs are also sensitive to the negative feedback regarding IL-12p70 further 
experiments, including DCs prepared from other compartments, were performed. 
In the experiments with BM-derived cells this part was investigated in more detail 
and will be discussed later.  
One of the main questions in this study was, whether the lack of ROS production 
due to a nonfunctional NADPH oxidase has any influence on the observed 
feedback mechanism. Therefore splenocytes of gp91
phox  deficient mice were 
compared with p47
phox deficient cells with respect to the negative feedback. The 
results demonstrated that the negative effect on TLR9-mediated IL-12p70 
secretion was dependent on p47
phox rather than on a functional NADPH oxidase 
complex. In subsequent inhibition experiments with the flavoprotein inhibitor DPI it 
was clearly demonstrated that the negative feedback regulation of TLR9-mediated 
IL-12p70 secretion is not influenced by gp91
phox (Cross, 1986; Radeke, 1991), 
which confirms a ROS-independent mechanism. Surprisingly, in this experimental 
series a negative feedback regarding IL-12p70 secretion also after stimulation of 
LPS in combination with DPI was discovered. These data suggest that the TRIF 
and MyD88 pathways downstream of TLR4 exhibit a differential sensitivity towards 
ROS inhibition. Hence, blocking a ROS-dependent TRIF signaling by DPI 
uncovered the LPS induced MyD88 pathway of the TLR4 signaling, which again is 
regulated by p47
phox. Based on the fact that the spleen consists of diverse cell 
types, not only DCs but also macrophages and neutrophils could be involved in 
ROS production. However there is a major difference between these phagocytic 
cells and DCs, especially with regard to the time course and level of ROS 5 Discussion    Richter 
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production and the acidification in the phagosomal compartments. Whereas DCs, 
with their main function being to present processed peptides as antigens to naïve 
T lymphocytes, are characterized by a continuous and sustained production of 
ROS, macrophages and neutrophils produce very rapidly high amounts of ROS, 
called “burst” (Savina, 2006). In addition, the function of ROS during antigen 
presentation by DCs may be limited by the secretion of catalases (Thoren, 2007). 
The obtained data demonstrating ROS production following TLR stimulation alone 
suggest that ROS in DCs might have a special function independent of 
phagocytosis. It has been shown that in DCs the NADPH oxidase is cryptic, which 
means that oxidase activation and ROS production, respectively, are only 
recovered upon TLR activation (Elsen, 2004). 
According to our hypothesis that p47
phox interacts with the TLR signaling cascade 
and based on the previous findings that the negative feedback regulation by 
p47
phox is apparent only in a TLR/MyD88 dependent pathway, mice deficient for 
the adaptor TRIF and MyD88, respectively were investigated. These experiments 
showed that the negative feedback regulation was also detectable in spleen cells 
of TRIF
-/- mice which support the idea that the feedback is restricted to the TLR-
MyD88 pathway. With respect to the confirmed ROS-independent results 
regarding IL-12p70 regulation by p47
phox it can be concluded that the signaling 
involved is only TLR-MyD88 dependent. It has been published that IL-12p70 
production in DCs is abolished when MyD88 is absent (Kawai, 1999; Hemmi, 
2003). In a more recent publication it has been described that only IL-12p70 was 
absent, whereas intracellular IL-12p40 was still detectable (Theiner, 2008). This 
finding reinforces the idea that p47
phox influences primarily IL-12p35 expression via 
the TLR-MyD88 pathway and, to a lesser extent, IL-12p40 expression. It is not yet 
clear, whether only the heterodimeric IL-12p70 or if, which of its subunits p35 and 
p40 are more important regulators in autoimmune diseases (Harbord, 2002; 
Becher, 2002; Gutcher and Becher, 2007). However, from the data of this study it 
could be supposed that the regulation of IL-12p35 and IL-12p70, respectively, by 
p47
phox particularly in DCs via the TLR/MyD88 pathway influences the 
development of autoimmune diseases. Mice lacking TLR9 or its adaptor molecule 
MyD88 are protected from experimental autoimmune encephalitis (Prinz, 2006). 
This fact is clearly supportive for our suggestion that the regulation and fine tuning 5 Discussion    Richter 
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of the TLR9/MyD88 pathway resulting in IL-12p70 production plays a major role in 
autoimmune diseases. 
Although all of the data so far point towards DCs as carriers of the observed 
p47
phox dependent feedback mechanism of TLR9-induced IL12p70, the 
continuation of our investigations includes the purification of DCs from the spleen 
with a typical DC marker, CD11c. As expected the negative feedback mechanism 
on IL-12p70 was detectable in the CD11c-positive fraction of splenocytes. Thus, 
by further refining the negative feedback by p47
phox to the CD11c
+ DC fraction it 
stresses its crucial role for the regulation of chronic inflammation and autoimmune 
diseases. Focusing more stringently on the point whether pDCs are the main 
carriers of the negative feedback, in following experiments DCs were generated 
from the BM of p47
phox deficient and WT mice. The data clearly demonstrated that 
the feedback sensitive to p47
phox only arises in GM-CSF differentiated BM cells. 
Although Flt3-L differentiated cells exhibited a strong IL-12p70 response the 
p47
phox effect was not discernible in those cells. Differentiation with Flt3-L resulted 
in a mixture of DCs including cDCs characterized by CD11c expression but no 
expression of B220 and pDCs which are alternate in their CD11c expression but 
are described as B220 positive cells. Thus, the feedback mechanism is maybe 
masked by the different cell types. The fact that GM-CSF differentiated cells also 
including inflammatory DCs derived from monocytes could explain the feedback 
mechanism in this population. Furthermore these cells produce IL-23 after TLR4 
and TLR9 stimulation but interestingly p47
phox deficiency has no influence on this 
cytokine. In contrast Flt3-L differentiated cells do not secrete IL-23 upon TLR4 or 
TLR9 stimulation. Although several hints are found within this study that IL-12p70 
producing, TLR9-positive and CD11c
+ DCs exhibit the negative feedback 
mechanism by p47
phox it is not completely clarified which specific subtype is the 
important one. Based on recent findings, that changes the classical view of DC 
development, one promising subpopulation carrying the feedback mechanism 
could be the monocyte-derived, GM-CSF-dependent, TLR9-positive inflammatory 
DC (Naik, 2007; Onai, 2007; Liu, 2009). Of course, to proof this hypothesis further 
investigations are needed. 
In mice and rats with different mutations of p47
phox it was demonstrated that this 
lack of p47
phox is associated with enhanced autoimmunity (Olofsson, 2003; 
Hultqvist, 2004). The p47
phox mediated mechanism for this effect, however, is not 5 Discussion    Richter 
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clarified, and currently several different possibilities have been suggested. First, 
release of ROS into endosomes may affect the processing of antigens and thereby 
change the priming capacity of DCs (Savina, 2006); second, p47
phox has been 
proposed to be critical for tryptophan metabolism in DC and thereby makes them 
less proinflammatory (Romani, 2008); and third, macrophages may be 
proinflammatory and more efficient antigen presenting cells, if they are deficient in 
ROS production (Gelderman, 2007). These mechanisms are all dependent on the 
function of p47
phox as a part of a NADPH oxidase complex. In contrast, the present 
investigation defines an additional, somewhat more appealing, mechanism that is 
independent of the oxidative burst: p47
phox may negatively regulate TLR9-
mediated IL-12p70 secretion of DCs by acting through an adaptor on the 
TLR/TRAF6 signaling cascade.  
After assembling all of this data regarding the regulatory function of p47
phox in DCs 
in vitro, the next interesting point was to investigate if the Th1 response mediated 
by IL-12p70 is influenced. Although our in vivo experiments with a delayed-type 
hypersensitivity-like immunization protocol would point toward an increased Th1 
response in p47
phox deficient mice, the consequence of this type of regulation is 
not completely clear. As detected in our previous results that type I IFNs are 
influenced by p47
phox and activated together with an increased IL12p70 secretion, 
it might operate to both drive and protect against chronic inflammation (Baccala, 
2007; Treschow, 2005). However, the results of our initial short-term in vivo 
experiments clearly point toward a prominent role of a missing negative feedback 
regulation by p47
phox for the development of an IL-12p70-dependent, Th1-
polarized response. As described before immunization with antigens in the 
absence of a polarizing adjuvant, i.e., in IFA only, usually leads to a Th2-type 
response (Yip, 1999). Classically, immunization with “complete Freund’s adjuvant” 
(IFA containing Mycobacterium tuberculosis) or IFA with inflammatory type A 
CpGs and antigen facilitate a Th1 response (Chu, 1997; Yip, 1999). In addition to 
the Th1 response the IL-23 driven Th17 axis has been investigated. Interestingly 
Th17 memory cells were detected and also a feedback mechanism comparable to 
the Th1 response was observed while no IL-23 expression was measurable in the 
LN cells ten days after immunization. From the data of the BM-derived DCs we 
knew already that IL-23 is not regulated by p47
phox. Of course it is known that other 
cytokines are involved in the differentiation and proliferation of Th17 cells but IL-23 5 Discussion    Richter 
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is the cytokine responsible for the survival of Th17 cells (Veldhoen, 2006). Though 
it may be possible that factors like IL-6 and TGFß may be involved in the initial 
skewing of naïve T cells towards Th17, and thus make IL-23 suspendible, the 
observed effects on Th17 axis are not completely understood and further studies 
have to be done into this specific finding. 
Concluding the data of the in vitro and in vivo experiments with p47
phox-/-, herein for 
the first time a new and strong regulator of the proinflammatory IL-12p70/Th1 
response has been identified, i.e. p47
phox. These findings offer the possibility to 
exploit the role of p47
phox for both the guidance of an anti-inflammatory therapy in 
autoimmunity or vice versa to elicit a strong anti-cancerogenic response.  
5.3 Role of Vitamin D3 on IL-12p70 expression 
In the third part of this thesis the immunomodulatory function of VD3 before and 
during stimulation of DCs with TLR ligands was investigated. In two different 
mouse strains splenocytes and CD11c
+ purified cells treated with VD3 diminished 
IL-12p70 secretion upon TLR stimulation was detected. Thereby the strongest 
effect was observed in cells which were incubated with VD3 also before TLR 
stimulation. These findings confirm the published results that VD3 inhibits the 
differentiation and maturation of DCs and furthermore the production of IL-12p70 
and specifically its subunit p35 in DCs (Lyakh, 2005). Already fifteen years ago the 
down-regulation of c-rel, an important NF-κB protein, which regulates the 
expression of p35 was demonstrated (Yu, 1995). Furthermore other NF-κB 
proteins such as rel-B are regulated by VD3 (Dong, 2003). VD3 was shown to 
inhibit factors essential for the differentiation of DCs such as IRF4 (Gauzi, 2005). 
In mice deficient for IRF4 CD4
+ DCs are completely absent (Tailor, 2006). Thus, it 
is obvious that the immunomodulatory function of VD3 is widely distributed on 
different factors controlling the immune response.  
Since it was shown that VD3 regulates the redox status by elevating the 
expression of p47
phox the association of VD3 with p47
phox regarding the IL-12p70 
secretion have been investigated (Deutsch, 1995; Sly, 2001). Herein, in initial 
experiments with WT and p47
phox deficient mice I could demonstrate that VD3 may 
have a stimulatory effect on p47
phox which consequently resulted in decreased IL-
12p70 upon TLR9 stimulation. Although also in p47
phox deficient mice TLR9 
induced IL-12p70 is down-regulated by VD3 treatment the effect on WT cells is 5 Discussion    Richter 
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about 40% stronger than in p47
phox-/- cells. Because in the cell VD3 has many 
different effects the influence on p47
phox may be only one part and thus may is not 
completely translated into the amount of IL-12p70 secretion. To investigate this 
influence in more detail further experiments are needed including the p47
phox 
expression and activation upon VD3 treatment. 
 
In conclusion the results of this thesis present three factors, Selenium, p47
phox and 
VD3, which at different levels of efficiency regulate the TLR mediated immune 
response of DCs. In the last years DCs became more important due to their 
specific regulation of immune responses either for prevention of autoimmunity or in 
cancer therapy. One potential regulatory mechanism for these approaches could 
be the IL-12p70 regulation by p47
phox, because with respect to this modulator the 
results obtained in this thesis are very promising.        6 Ou
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8 APPENDIX 
8.1 Abbreviations 
A        A d e n i n e  
APC     Antigen  presenting  cell 
APS       Ammonium  peroxo-disulfate 
bp       Basepairs 
BCA       Bicinchoninic  acid     
BM       Bone  marrow 
BSA       Bovine  serum  albumin 
C       Cytosine 
CD     Cluster  of  differentiation 
cDC     Conventional  DCs 
cDNA       Copy  DNA,  complementary  DNA 
CGD     Chronic  granulomatous  disease 
CIA     Collagen-induced  arthritis 
CTL     Cytotoxic  T  lymphocytes 
DC       Dendritic  cell 
DNA       Desoxy  ribonucleic  acid 
dNTP       Desoxynucleoside  triphosphate 
DTT       Dithiotreitol 
EAE     Experimental  autoimmune encephalomyelitis 
EDTA      Ethylendiaminetetraacetic acid 
ELISA       Enzyme linked Immunosorbent assay 
ELISPOT      Enzyme linked immuno spot 
ER     Endoplasmatic  reticulum 
EtOH       Ethanol 
FACS      Fluorescence  activated  cell  sorting 
Fc     Fragment  crystallizable 
FCS       Fetal  calf  serum 
Flt3         FMS-like tyrosine kinase 3 
G       Guanine 
GAPDH    Glyceraldehyde-3-phosphate  dehydrogenase 
GM-CSF      Granulocyte  macrophage-colony stimulating factor 8 Appendix    Richter 
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HEPES      N-(2-Hydroxyethyl)piperazine-N'-ethanesulfonic  acid 
HMGB1      High-mobility group box 1 
HRP     Horseradish  peroxidase 
IBD     Inflammatory  bowel  diseases 
IFA     Incomplete  Freund’s  adjuvant 
IFN       Interferon   
IgG     Immunoglobulin  G 
IKK     Inhibitor  of  nuclear  factor-κB (IκB)-kinase 
IL       Interleukin 
iLC     Immature  Langerhans  cells 
IRAK       IL-1R-associated  kinase 
IRF     Interferon  regulatory  factor 
JAK     Janus  kinase 
k b        K i l o b a s e  
k D        K i l o d a l t o n  
LN     Lymph  node 
LBP     LPS-binding  protein 
LPS       Lipopolysaccharide 
LRRs     Leucin  rich  repeats 
MAPK     Mitogen-activated  protein  kinase 
MHC     Major  histocompatibility  complex 
MS     Multiple  sclerosis 
MyD88      Myeloid  differentiation primary response gene (88) 
NADPH    Nicotinamide  adenine dinucleotide phosphate 
NEA       Non-essential  amino  acids 
NEMO   NF-κB essential modulator 
NF-κB      Nuclear  factor  κB 
NK     Natural  killer 
NP-40     Nonidet  P-40 
ODN     Oligodeoxynucleotide 
OVA     Ovalbumin 
PAA     Polyacrylamide 
PBS       Phosphate  buffered  saline 
PCR       Polymerase  chain  reaction 8 Appendix    Richter 
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pDC     Plasmacytoid  DCs 
phox       Phagocyte  oxidase 
PIA     Pristane  induced  arthritis 
PRR     Pattern  recognition  receptor 
RA     Rheumatoid  arthritis 
ROS     Reactive  oxygen  species 
rpm       Rounds  per  minute 
RT-PCR       Reverse transcribed-polymerase chain reaction 
s.c.     subcutan 
SD     Standard  deviation 
SDS       Sodiumdodecyl  sulfate 
Se     Selenium 
SLE     Systemic  lupus  erythematosus 
STAT       Signal transducer and activator of transcription 
T       Thymine 
T1D        Type I insulin-dependent diabetes mellitus  
TAE     Tris  Acetate  EDTA 
TAB     TAK1-binding  protein 
TAK1     transforming  growth  factor (TGF) -activated kinase 1 
TANK     TRAF  family  member-associated  NF-κB activator 
TBK1     TANK  binding  kinase  1 
TEMED      N,N,N',N'  -  tetramethylethylene  diamine 
Th     T  helper 
TIR     Toll/IL-1  receptor 
TIRAP     TIR  domain-containing  adaptor  protein 
TLR       Toll-like  receptor 
TNF     Tumor  necrosis  factor 
TRAF     TNF  receptor-associated  factor 
TRIF       TIR-domain-containing adapter-inducing interferon-β 
U       Units 
UV       Ultraviolet  (light) 
VD3       V i t a m i n   D 3 
VDR     VD  receptor 
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8.2 Deutsche Zusammenfassung 
Dendritische Zellen gelten als „Wächter“ zwischen der angeborenen und der 
erworbenen Immunität. Sie sind professionelle Antigen-präsentierende Zellen, die 
eindringende Pathogen finden, über spezielle Rezeptoren, wie Toll-like 
Rezeptoren, mikrobielle Strukturen erkennen und daraufhin eine gezielte T-Zell 
Antwort induzieren. Für die Ausrichtung der naiven T-Zellen sind TLR-induzierte 
Zytokine verantwortlich. Die Erkennung und Unterscheidung mikrobieller, fremder 
Muster und körpereigener Strukturen über TLRs ist fein abgestimmt, aber dennoch 
kann es unter bestimmten Umständen zu einer Dysregulation der Immunantwort 
kommen. Die Konsequenz kann eine unkontrollierte Immunantwort sein, welche 
sich in Autoimmunität, chronisch-entzündlichen Erkrankungen oder Krebs 
wiederspiegelt. In dieser Dissertation lag der Fokus auf zwei Zytokinen der IL-12 
Familie, IL-12p70 und IL-23, produziert von DCs. Das Ziel der Arbeit war die 
Untersuchung von drei endogenen bzw. exogenen Faktoren, welche IL-12p70 
oder IL-23 regulieren könnten.  
Im ersten Teil der Arbeit wurde Selen, ein essenzielles Spurenelement und ein 
wichtiger Faktor in vielen Stoffwechselwegen inklusive Sauerstoffradikal-/Redox -
Status, als Zusatz in einer DC Zellkultur verwendet. Da Selen auch eine wichtige 
Rolle im Immunsystem zugesprochen wird, wurde die TLR-induzierte IL-23 
Produktion der DCs nach Selenbehandlung analysiert. In der unreifen 
Langerhanszelllinie XS-52 war der stärkste Stimulus für die IL-23 Produktion der 
TLR4 Ligand LPS. Desweiteren konnte eine erhöhte Menge TLR4-induziertes IL-
23 in den Selen-behandelten Zellen, konzentrationsabhängig, beobachtet werden. 
Während die IL-23 Untereinheit p40 durch Selen herauf reguliert wurde, war die 
zweite Untereinheit p19 unbeeinflusst durch Selen. Diesen Effekt konnte sowohl 
auf mRNA als auch auf Protein Ebene detektiert werden. Zusätzlich, wie auch zu 
erwarten, hat die gleichzeitige Stimulation mit IFN-γ die IL-23 Produktion in nicht 
behandelten und Selen-behandelten inhibiert. 
Im zweiten Abschnitt der Dissertation sollte p47
phox, ein Organisationsprotein der 
NADPH oxidase bezüglich seines regulatorischen Potenzials für die IL-12p70 und 
IL-23 Produktion in verschiedenen DC Typen analysiert werden. Seit gezeigt 
wurde, dass p47
phox Defizienz mit erhöhter Autoimmunität und chronischer 
Entzündung assoziiert ist, sollte geprüft werden, ob p47
phox eine zusätzliche 
Funktion neben seiner Rolle innerhalb der NADPH oxidase besitzt. Es gibt einige 8 Appendix    Richter 
113 
 
Hinweise, dass p47
phox mit bestimmten Proteinen des TLR Signalweges 
interagieren kann. Daraus ableitend wurde für diese Arbeit die Hypothese 
aufgestellt, dass p47
phox eine regulatorische Funktion für die TLR-induzierte 
Zytokinproduktion in DCs haben könnte. In mehreren Experimenten in Milzzellen 
p47
phox defizienter Mäuse konnte eine erhöhte IL-12p70 Antwort nach TLR9 
Stimulation im Vergleich zu Wildtyp Zellen detektiert werden. Im Gegensatz zu 
TLR9 war die TLR4-induzierte IL-12p70 Produktion nicht unterschiedlich. In 
Milzzellen konnt generell kein IL-23 gemessen werden. Um die Ergebnisse 
bezüglich dieser neu beschriebenen negativen Rückkopplung auf IL-12p70 durch 
p47
phox zu bestätigen wurden Ratten mit einem Einzelnukleotid-Polymorphismus 
im p47
phox Gen untersucht. Interessanterweise befindet sich dieser 
Polymorphismus an einer Phosphorylierungsstelle der IRAK4, einer wichtigen 
Kinase im TLR Signalweg. In Ratten, welche für Methionin an dieser Stelle 
kodieren, war die TLR-induzierte IL-12p70 Antwort im Vergleich zu den Ratten mit 
einem Threonin an dieser Position deutlich erhöht. Threonin kann im Gegensatz 
zu Methionin durch IRAK4 phosphoryliert werden. Alle untersuchten Mäuse und 
Ratten sind durch einen Defekt in der NADPH Oxidase gekennzeichnet, welcher 
durch ein nicht funktionelles p47
phox Protein entsteht und sind somit nicht in der 
Lage Sauerstoffradikale, ROS, zu produzieren. Um zu zeigen, dass die fehlende 
negative Rückkopplung in p47
phox defizienten und mutierten Zellen nicht durch das 
Fehlen von Sauerstoffradikalen zustande kommt, wurden Kontrollexperimente mit 
gp91
phox Mäusen durchgeführt. Diese Tiere sind ebenfalls durch eine defekte 
NADPH Oxidase Funktion charakterisiert. In mehreren Experimenten konnte 
gezeigt werden, dass die gp91
phox defizienten Zellen keine Unterschiede bezüglich 
der negativen Rückkopplung auf IL-12p70 zu Wildtyp Zellen aufweisen. In 
weiteren Untersuchungen mit einem Inhibitor der NADPH Oxidase wurden 
ebenfalls keine Effekte auf die negative Rückkopplung gemessen. 
Interessanterweise wurde aber mit Hilfe des Inhibitors auch nach TLR4 
Stimulation ein negativer Rückkopplungseffekt auf IL-12p70 in Wildtyp Zellen 
detektiert. Somit konnte nachgewiesen werden, dass die Blockade des ROS-
abhängigen TLR4 Weges den ROS-unabhängigen Teil des TLR4 Signalweges 
aufdeckt, welcher zuvor nicht sichtbar war. Diese Befunde zeigen deutlich, dass 
p47
phox eine NADPH Oxidase-unabhängige Funktion besitzt. Da Milzzellen kein IL-
23 produzieren wurden DCs, welche zuvor aus dem Knochenmark differenziert 8 Appendix    Richter 
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wurden, hinsichtlich der negativen Rückkopplung untersucht. In DCs aus p47
phox 
defizienten Mäusen, differenziert mit GM-CSF, konnte eine erhöhte IL-12p70 
Produktion nachbewiesen werden. Im Gegensatz dazu zeigten Flt3-L 
differenzierte Knochenmarkzellen aus p47
phox defizienten und Wildtyp Mäusen 
keine Unterschiede in der IL-12p70 Menge. Für IL-23 konnte weder in GM-CSF 
noch in Flt3-L differenzierten Zellen eine negative Rückkopplung detektiert 
werden. Somit konnte gezeigt werden, dass IL-23 nicht durch p47
phox reguliert 
wird. IL-12p70 ist das wichtigste Zytokin für die Ausrichtung naiver T Zellen in Th1 
Zellen, während IL-23 für die Erhaltung und das Überleben von Th17 Zellen 
essenziell ist. Um zu überprüfen, ob die Regulation von IL-12p70 durch p47
phox 
auch die T-Zell Antwort beeinflusst, wurden Immunisierungsexperimente, 
vergleichbar zu den klassischen DTH Protokollen, durchgeführt. Verschieden 
Gruppen von p47
phox defizienten und Wildtyp Mäusen erhielten s.c. entweder PBS, 
OVA oder OVA in Kombination mit dem TLR9 Liganden CpG2216 in IFA. Dies 
sollte die Aktivierung und Polarisierung naiver T-Zellen in Th1 oder Th17 Zellen 
fördern. Nach 10 Tagen wurden die regionalen Lymphknoten entnommen, die 
Zellen in einem ELISA spot assay mit oder ohne OVA re-stimuliert und die 
Frequenz an IFN-γ bzw. IL-17 produzierenden T-Zellen gemessen. Die erneute 
Stimulation mit OVA in vitro verstärkte die IFN-γ und IL-17 Antwort in p47
phox 
defizienten Zellen. Die Kombination mit CpG2216 als Adjuvans und Auslöser des 
3. Signals erhöhte die Frequenz von IFN-γ bzw. IL-17 in Wildtyp Zellen deutlich. 
Darüberhinaus war die Antwort in p47
phox defizienten Zellen, welche bereits ohne 
erneute OVA Stimulation verstärkt war, gegenüber dem Wildtyp signifikant erhöht. 
Somit bestärken diese Befunde auch die in vitro Daten bezüglich IL-12p70 
Regulation und darüberhinaus die Wichtigkeit der p47
phox Regulation als 
zusätzlicher Mechanismus zur Kontrolle der Immunantwort.  
Im letzten Teil der Arbeit wurde die immunregulatorische Funktion von Vitamin D3 
untersucht. Nachdem gezeigt wurde, dass VD3 die Differenzierung und Reifung 
von Monozyten und DCs beeinflusst, wurden DCs aus Milzzellen von C57BL/6 
und BALB/c Mäusen bezüglich IL-12p70 Produktion nach VD3 Behandlung 
untersucht. Milzzellen welche mit LPS oder CpG2218 stimuliert wurden zeigten 
eine verminderte IL-12p70 Produktion wenn sie mit VD3 vor der Stimulation 
behandelt wurden. Dagegen hatte die Behandlung mit VD3 ausschließlich 
während der Stimulation keinen Einfluss. Es ist bekannt, dass VD3 die mRNA von 8 Appendix    Richter 
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p47
phox herauf regulieren kann. Somit wurden in ersten Experimenten auch p47
phox 
defiziente Zellen mit VD3 behandelt und es konnte, verglichen zum Wildtyp, nur 
eine leichte Inhibition der IL-12p70 Menge detektiert werden. 
Zusammenfassend zeigen die Daten dieser Dissertation drei verschiedene 
Möglichkeiten die TLR-induzierte Zytokinproduktion von DCs zu regulieren, wenn 
auch mit unterschiedlicher Intensität und Spezifität. 
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